Massachusetts Institute of Technology
Basic Medical Research Award | For discoveries concerning integrins – key mediators of cell-matrix and cell-cell interactions in physiology and disease. | 2022 | Sanford Burnham Prebys Medical Discovery Institute | Basic Medical Research Award | For discoveries concerning integrins – key mediators of cell-matrix and cell-cell interactions in physiology and disease. |
2022 | Boston Children’s Hospital | Basic Medical Research Award | For discoveries concerning integrins – key mediators of cell-matrix and cell-cell interactions in physiology and disease. |
2021 | Stanford University | Basic Medical Research Award | For the discovery of light-sensitive microbial proteins that can activate or silence individual brain cells and for their use in developing optogenetics—a revolutionary technique for neuroscience. |
2021 | BioNTech | Clinical Medical Research Award | For the discovery of a new therapeutic technology based on the modification of messenger RNA—enabling rapid development of highly effective Covid-19 vaccines. |
2021 | University of Pennsylvania | Clinical Medical Research Award | For the discovery of a new therapeutic technology based on the modification of messenger RNA—enabling rapid development of highly effective Covid-19 vaccines. |
2021 | California Institute of Technology | Special Achievement Award in Medical Science | As one of the premier biomedical scientists of the last five decades, he is renowned for the breadth and beauty of his discoveries in virology, immunology, and cancer; for his academic leadership; for his mentorship of prominent scientists; and for his influence as a public advocate for science. |
2019 | Emory University School of Medicine | Basic Medical Research Award | For their discovery of the two distinct classes of lymphocytes, B and T cells – a monumental achievement that provided the organizing principle of the adaptive immune system and launched the course of modern immunology. |
2019 | University of California, Los Angeles | Clinical Medical Research Award | For their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer. |
2018 | The Rockefeller University | Basic Medical Research Award | For discoveries elucidating how gene expression is influenced by chemical modification of histones—the proteins that package DNA within chromosomes. |
2018 | University of California, Los Angeles | Basic Medical Research Award | For discoveries elucidating how gene expression is influenced by chemical modification of histones—the proteins that package DNA within chromosomes. |
2018 | Yale University | Special Achievement Award in Medical Science | For four decades of leadership in biomedical science—exemplified by pioneering discoveries in RNA biology, generous mentorship of budding scientists, and vigorous and passionate support of women in science. |
2017 | National Cancer Institute (NCI) Center for Cancer Research (CCR) | Clinical Medical Research Award | For technological advances that enabled development of human papillomaviruses (HPV) vaccines for prevention of cervical cancer and other tumors caused by HPV. |
2017 | National Cancer Institute (NCI) Center for Cancer Research (CCR) | Clinical Medical Research Award | For technological advances that enabled development of human papillomaviruses (HPV) vaccines for prevention of cervical cancer and other tumors caused by HPV. |
2016 | University of California, San Francisco | Special Achievement Award in Medical Science | For fundamental discoveries in DNA replication and protein biochemistry; for visionary leadership in directing national and international scientific organizations to better people’s lives; and for passionate dedication to improving education in science and mathematics. |
2016 | Dana-Farber Cancer Institute/Harvard Medical School | Basic Medical Research Award | For the discovery of the pathway by which cells from humans and most animals sense and adapt to changes in oxygen availability – a process essential for survival. |
2016 | Johns Hopkins University School of Medicine | Basic Medical Research Award | For the discovery of the pathway by which cells from humans and most animals sense and adapt to changes in oxygen availability – a process essential for survival. |
2016 | formerly at Pharmasset; now at Arbutus Biopharma | Clinical Medical Research Award | For development of a system to study the replication of the virus that causes hepatitis C and for use of this system to revolutionize the treatment of this chronic, often lethal disease. |
2015 | University of Texas MD Anderson Cancer Center | Clinical Medical Research Award | For the discovery and development of a monoclonal antibody therapy that unleashes the immune system to combat cancer. |
2015 | Harvard Medical School and Brigham and Women’s Hospital | Basic Medical Research Award | For discoveries concerning the DNA-damage response—a fundamental mechanism that protects the genomes of all living organisms. |
2014 | University of Washington | Special Achievement Award in Medical Science | For bold, imaginative, and diverse contributions to medical science and human rights — she discovered the BRCA1 gene locus that causes hereditary breast cancer and deployed DNA strategies that reunite missing persons or their remains with their families. |
2014 | University of California, San Francisco | Basic Medical Research Award | For discoveries concerning the unfolded protein response — an intracellular quality control system that detects harmful misfolded proteins in the endoplasmic reticulum and signals the nucleus to carry out corrective measures. |
2014 | Emory University School of Medicine | Clinical Medical Research Award | For the development of deep brain stimulation of the subthalamic nucleus, a surgical technique that reduces tremors and restores motor function in patients with advanced Parkinson's disease. |
2013 | University of Melbourne | Clinical Medical Research Award | For the development of the modern cochlear implant — a device that bestows hearing to individuals with profound deafness. |
2013 | Genentech | Basic Medical Research Award | For discoveries concerning the molecular machinery and regulatory mechanism that underlie the rapid release of neurotransmitters. |
2013 | Stanford University School of Medicine | Basic Medical Research Award | For discoveries concerning the molecular machinery and regulatory mechanism that underlie the rapid release of neurotransmitters. |
2013 | Duke University | Clinical Medical Research Award | For the development of the modern cochlear implant — a device that bestows hearing to individuals with profound deafness. |
2012 | Carnegie Institution of Washington, Department of Embryology | Special Achievement in Medical Science | For exceptional leadership and citizenship in biomedical science — exemplified by fundamental discoveries concerning the nature of genes; by selfless commitment to young scientists; and by disseminating revolutionary technologies to the scientific community. |
2012 | University of Cambridge | Clinical Medical Research Award | For the development of liver transplantation, which has restored normal life to thousands of patients with end-stage liver disease. |
2012 | Columbia University, Department of Biochemistry & Biophysics | Special Achievement Award in Medical Science | For exceptional leadership and citizenship in biomedical science — exemplified by fundamental discoveries concerning the nature of genes; by selfless commitment to young scientists; and by disseminating revolutionary technologies to the scientific community. |
2012 | Columbia University, Department of Biological Sciences | Basic Medical Research Award | For discoveries concerning cytoskeletal motor proteins, machines that move cargoes within cells, contract muscles, and enable cell movements. |
2012 | Stanford University School of Medicine | Basic Medical Research Award | For discoveries concerning cytoskeletal motor proteins, machines that move cargoes within cells, contract muscles, and enable cell movements. |
2012 | University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute | Clinical Medical Research Award | For the development of liver transplantation, which has restored normal life to thousands of patients with end-stage liver disease. |
2012 | University of California, San Francisco (UCSF) | Basic Medical Research Award | For discoveries concerning cytoskeletal motor proteins, machines that move cargoes within cells, contract muscles, and enable cell movements. |
2011 | Max Planck Institute of Biochemistry, Department of Cellular Biochemistry | Basic Medical Research Award | For discoveries concerning the cell's protein-folding machinery, exemplified by cage-like structures that convert newly made proteins into their biologically active forms. |
2011 | Yale University School of Medicine, Department of Genetics | Basic Medical Research Award | For discoveries concerning the cell's protein-folding machinery, exemplified by cage-like structures that convert newly made proteins into their biologically active forms. |
2011 | | Lasker-Bloomberg, Public Service | For serving since its inception as a model research hospital — providing innovative therapy and high-quality patient care, treating rare and severe diseases, and producing outstanding physician-scientists whose collective work has set a standard of excellence in biomedical research. |
2010 | Jackson Laboratory | Basic Medical Research Award | For the discovery of leptin, a hormone that regulates appetite and body weight—a breakthrough that opened obesity research to molecular exploration. |
2010 | Genentech, Inc., Department of Molecular Oncology | Clinical Medical Research Award | For the discovery of VEGF as a major mediator of angiogenesis and the development of an effective anti-VEGF therapy for wet macular degeneration, a leading cause of blindness in the elderly. |
2010 | Rockefeller University, Laboratory of Molecular Genetics | Basic Medical Research Award | For the discovery of leptin, a hormone that regulates appetite and body weight—a breakthrough that opened obesity research to molecular exploration. |
2010 | Oxford University, Weatherall Institute of Molecular Medicine | Special Achievement Award in Medical Science | For 50 years of international statesmanship in biomedical science—exemplified by discoveries concerning genetic diseases of the blood and for leadership in improving clinical care for thousands of children with thalassemia throughout the developing world. |
2009 | Oregon Health & Science University, Knight Cancer Institute | Clinical Medical Research Award | For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition. |
2009 | Sloan-Kettering- Memorial Sloan-Kettering Cancer Center | Clinical Medical Research Award | For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition. |
2009 | Institute for Integrated Cell-Material Sciences, Kyoto University | Basic Medical Research Award | For discoveries concerning nuclear reprogramming, the process that instructs specialized adult cells to form early stem cells — creating the potential to become any type of mature cell for experimental or therapeutic purposes. |
2008 | University of Massachusetts Medical School, Department of Molecular Medicine | Basic Medical Research Award | For discoveries that revealed an unanticipated world of tiny RNAs that regulate gene function in plants and animals |
2008 | University of Cambridge, Department of Plant Sciences | Basic Medical Research Award | For discoveries that revealed an unanticipated world of tiny RNAs that regulate gene function in plants and animals. |
2008 | Stanford University School of Medicine | Special Achievement Award in Medical Science | For a 51-year career as one of the great microbe hunters of all time — he discovered the molecular nature of antibiotic resistance, revolutionized the way we think about how pathogens cause disease, and mentored more than 100 students, many of whom are now distinguished leaders in the fields of microbiology and infectious diseases |
2008 | Harvard Medical School, Massachusetts General Hospital | Basic Medical Research Award | For discoveries that revealed an unanticipated world of tiny RNAs that regulate gene function in plants and animals. |
2007 | Providence Health and Services | Clinical Medical Research Award | For the development of prosthetic mitral and aortic valves, which have prolonged and enhanced the lives of millions of people with heart disease. |
2007 | Rockefeller University | Basic Medical Research Award | For the discovery of dendritic cells—the preeminent component of the immune system that initiates and regulates the body's response to foreign antigens. |
2007 | NIH | Public Service Award | For his role as the principal architect of two major U.S. governmental programs, one aimed at AIDS and the other at biodefense. |
2006 | University of Pennsylvania, Department of Psychiatry | Clinical Medical Research Award | For the development of cognitive therapy, which has transformed the understanding and treatment of many psychiatric conditions, including depression, suicidal behavior, generalized anxiety, panic attacks, and eating disorders. |
2006 | UCSF, Department of Biochemistry & Biophysics | Basic Medical Research Award | For the prediction and discovery of telomerase, a remarkable RNA-containing enzyme that synthesizes the ends of chromosomes, protecting them and maintaining the integrity of the genome. |
2006 | Carnegie Institution for Science, Department of Embryology | Special Achievement in Medical Science | For a distinguished 57-year career—as a founder of modern cell biology and the field of chromosome structure and function; bold experimentalist; inventor of in situ hybridization; and early champion of women in science. |
2006 | JHU School of Medicine, Department of Molecular Biology & Genetics | Basic Medical Research Award | For the prediction and discovery of telomerase, a remarkable RNA-containing enzyme that synthesizes the ends of chromosomes, protecting them and maintaining the integrity of the genome |
2006 | Harvard Medical School | Basic Medical Research Award | For the prediction and discovery of telomerase, a remarkable RNA-containing enzyme that synthesizes the ends of chromosomes, protecting them and maintaining the integrity of the genome. |
2004 | Salk Institute for Biological Studies | Basic Medical Research Award | For the discovery of the superfamily of nuclear hormone receptors and elucidation of a unifying mechanism that regulates embryonic development and diverse metabolic pathways. |
2004 | University of Cincinnati Medical Center, Vontz Center for Molecular Studies | Basic Medical Research Award | For the discovery of the superfamily of nuclear hormone receptors and elucidation of a unifying mechanism that regulates embryonic development and diverse metabolic pathways. |
2004 | Harvard University, Department of Molecular & Cell Biology | Special Achievement Award in Medical Science | For a lifetime career that combines penetrating discovery in molecular biology with creative leadership in the public policy of chemical and biological weapons. |
2003 | Kennedy Institute of Rheumatology, Imperial College London | Clinical Medical Research Award | For discovery of anti-TNF therapy as an effective treatment for rheumatoid arthritis and other autoimmune diseases. |
2003 | | Basic Medical Research Award | For pioneering studies on eukaryotic RNA polymerases and the general transcriptional machinery, which opened gene expression in animal cells to biochemical analysis. |
2002 | Rockefeller University | Special Achievement in Medical Science | For an exceptional career in biomedical science during which he opened two fields in biology — RNA processing and cytokine signaling — and fostered the development of many creative scientists. |
2002 | University of Utah School of Medicine | Clinical Medical Research Award | For the development of renal hemodialysis, which changed kidney failure from a fatal to a treatable disease, prolonging the useful lives of millions of patients. |
2002 | Memorial Sloan-Kettering Cancer Center | Basic Medical Research Award | For discoveries revealing the universal machinery that orchestrates the budding and fusion of membrane vesicles — a process essential to organelle formation, nutrient uptake, and secretion of hormones and neurotransmitters. |
2002 | University of California, Berkeley, Department of Molecular and Cell Biology | Basic Medical Research Award | For discoveries revealing the universal machinery that orchestrates the budding and fusion of membrane vesicles — a process essential to organelle formation, nutrient uptake, and secretion of hormones and neurotransmitters. |
2002 | University of Washington | Clinical Medical Research Award | For the development of renal hemodialysis, which changed kidney failure from a fatal to a treatable disease, prolonging the useful lives of millions of patients. |
2001 | University of Utah, Department of Human Genetics | Basic Medical Research Award | For the development of a powerful technology for manipulating the mouse genome with exquisite precision, which allows the creation of animal models of human disease |
2001 | University of North Carolina at Chapel Hill | Basic Medical Research Award | For the development of a powerful technology for manipulating the mouse genome with exquisite precision, which allows the creation of animal models of human disease. |
2000 | American Cancer Society | Mary Woodard Lasker Award for Public Service | For enlightening scientists and the public about the relationship between race, poverty and cancer. |
2000 | Technion-Israel Institute of Technology, Department of Biochemistry | Basic Medical Research Award | For the discovery and the recognition of the significance of the ubiquitin system of regulated protein degradation, a fundamental process that influences vital cellular events, including the cell cycle, malignant transformation, and responses to inflammation and immunity. |
2000 | Chiron Corporation | Clinical Medical Research Award | For pioneering work leading to the discovery of the virus that causes hepatitis C and the development of screening methods that reduced the risk of blood transfusion-associated hepatitis in the U.S. from 30 percent in 1970 to virtually zero in 2000. |
2000 | California Institute of Technology, Division of Biology | Basic Medical Research Award | For the discovery and the recognition of the significance of the ubiquitin system of regulated protein degradation, a fundamental process that influences vital cellular events, including the cell cycle, malignant transformation, and responses to inflammation and immunity. |
2000 | NIH | Clinical Medical Research Award | For pioneering work leading to the discovery of the virus that causes hepatitis C and the development of screening methods that reduced the risk of blood transfusion-associated hepatitis in the U.S. from 30 percent in 1970 to virtually zero in 2000. |
1999 | University of Pennsylvania School of Medicine, Department of Physiology | Basic Medical Research Award | For elucidating the functional and structural architecture of ion channel proteins, which govern the electrical potential of membranes throughout nature, thereby generating nerve impulses and controlling muscle contraction, cardiac rhythm, and hormone secretion. |
1999 | University of Washington School of Medicine, Department of Physiology & Biophysics | Basic Medical Research Award | For elucidating the functional and structural architecture of ion channel proteins, which govern the electrical potential of membranes throughout nature, thereby generating nerve impulses and controlling muscle contraction, cardiac rhythm, and hormone secretion. |
1999 | Rockefeller University | Basic Medical Research Award | For elucidating the functional and structural architecture of ion channel proteins, which govern the electrical potential of membranes throughout nature, thereby generating nerve impulses and controlling muscle contraction, cardiac rhythm, and hormone secretion. |
1999 | Harvard Medical School | Special Achievement in Medical Science | For a lifetime of contributions to neuroscience — including discovery of a method for measuring cerebral blood flow that led to current brain imaging techniques, adoptive studies in schizophrenia that established its genetic origin, and visionary leadership in mental health that ushered psychiatry into the molecular era. |
1998 | Fred Hutchinson Cancer Research Center | Basic Medical Research Award | For pioneering genetic and molecular studies that revealed the universal machinery for regulating cell division in all eukaryotic organisms, from yeasts to frogs to human beings. |
1998 | Fox Chase Cancer Center | Clinical Medical Research Award | For incisive studies in patient-oriented research that paved the way for identifying genetic alterations that cause cancer in humans and that allow for cancer diagnosis in patients at the molecular level. |
1998 | University of Pennsylvania School of Medicine, Department of Pathology & Laboratory Medicine | Clinical Medical Research Award | For incisive studies in patient-oriented research that paved the way for identifying genetic alterations that cause cancer in humans and that allow for cancer diagnosis in patients at the molecular level. |
1998 | University of Chicago Medical Center | Clinical Medical Research Award | For incisive studies in patient-oriented research that paved the way for identifying genetic alterations that cause cancer in humans and that allow for cancer diagnosis in patients at the molecular level. |
1997 | Johns Hopkins University | Special Achievement Award in Medical Science | For a lifetime career as founder of the discipline of clinical genetics. |
1997 | Harvard University | Basic Medical Research Award | For elegant and incisive discoveries leading to the understanding of how regulatory proteins control the transcription of genes. |
1997 | Johns Hopkins UniversityBloomberg School of Public Health | Clinical Medical Research Award | For the understanding and demonstration that low-dose vitamin A supplementation in millions of third world children can prevent death from infectious diseases as well as blindness. |
1996 | University of Rochester Medical School, Department of Pediatrics & Microbiology | Clinical Medical Research Award | For groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus. |
1996 | State University of New York Health Science Center at Brooklyn (SUNY) | Basic Medical Research Award | For the landmark discovery of endothelium-derived relaxing factor (EDRF), now known to be nitric oxide, and other research findings that have profound implications for the treatment of cardiovascular conditions and other diseases. |
1996 | GWU Department of Biochemistry & Molecular Biology (Molecular Geriatrics Corporation) | Basic Medical Research Award | For ingenious elucidation of the cyclic GMP signaling pathway of nitric oxide and for essential discoveries that led to establishing the link between endothelium-derived relaxing factor and nitric oxide. |
1996 | Worcester Foundation for Biomedical Research | Special Achievement Award in Medical Science | For brilliant and original science that revolutionized biochemistry and spawned new avenues of scientific inquiry. |
1996 | NIH | Clinical Medical Research Award | For groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus. |
1996 | NIH | Clinical Medical Research Award | For groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus. |
1995 | University of Melbourne, Department of Immunology and Microbiology (St. Jude Children's Research Hospital) | Basic Medical Research Award | For the epochal discovery of MHC restriction of T-cell recognition and the single T-cell receptor altered-self hypothesis. |
1995 | Harvard University, Department of Molecular & Cellular Biology | Basic Medical Research Award | For pioneering the isolation of and solution to the structures of class I and class II MHC proteins and their peptide complexes. |
1995 | Washington University, Department of Pathology and Immunology | Basic Medical Research Award | For seminal discoveries in antigen processing and MHC-peptide binding which deciphered the biochemical basis of T-cell recognition. |
1995 | Harvard University | Basic Medical Research Award | For visualizing the three-dimensional structures of class I and class II proteins and their complexes with antigens and superantigens. |
1995 | University Hospital of Zurich, Institute of Experimental Immunology | Basic Medical Research Award | For the landmark discovery of MHC restriction of T-cell recognition, and the altered-self hypothesis. |
1994 | UCSF, Department of Pediatrics and Neonatology | Clinical Medical Research Award | For his brilliant studies defining and describing the role of pulmonary surfactant and in developing a life-saving artificial surfactant now used in premature infants around the world. |
1994 | UCSF Institute for Neurodegenerative Diseases | Basic Medical Research Award | For landmark, revolutionary work that established the existence of an entirely new class of infectious agents, and which opened new understanding of the pathogenesis of several baffling neurodegenerative diseases. |
1993 | Rockefeller University, Laboratory of Cell Biology | Basic Medical Research Award | For landmark discoveries concerning the processes by which intercellular proteins are targeted across cell membranes. |
1993 | Walter and Eliza Hall Institute of Medical Research, Division of Cancer & Haematology | Clinical Medical Research Award | For his outstanding discovery of the colony-stimulating factors, two of which are widely used to treat patients with cancer and diseases of blood cell formation. |
1993 | Columbia University College of Physicians and Surgeons | Public Service Award | For her groundbreaking work in the scientific and public arenas towards finding a cure for Huntington's disease and for increasing awareness of all genetic disease. |
1991 | UCSF Depts. of Pathology & Laboratory Medicine | Clinical Medical Research Award | For his pivotal contributions to the development of human genetics, most importantly in the area of the hemoglobinopathies using recombinant DNA technology. |
1991 | California Institute of Technology | Basic Medical Research Award | For fundamental research on the Bithorax complex, which established the role of homeotic genes in the development of cell patterns and provided a foundation for current studies of embryonic development. |
1989 | University of Texas Southwestern Medical Center | Basic Medical Research Award | For his pioneering studies of signal transduction and for his discovery that G-proteins carry signals that regulate vital processes within cells. |
1989 | University of Washington School of Medicine | Basic Medical Research Award | For his seminal finding that phosphorylation activates major enzymes in cells, and for perceiving the profound importance of protein kinase enzymes. |
1988 | University of Colorado at Boulder, Department of Chemistry & Biochemistry | Basic Medical Research Award | For his revolutionary research revealing the enzymatic role of RNA, opening a new universe in molecular biology. |
1988 | Rockefeller University | Clinical Medical Research Award | For postulating the physiological basis of narcotic addiction and for developing methadone treatment for heroin addiction. |
1988 | Massachusetts Institute of Technology Center for Cancer Research | Basic Medical Research Award | For his series of revelations regarding the ability of RNA processing to convert DNA's massive store of genetic data to biological use. |
1987 | California Institute of Technology | Basic Medical Research Award | For his prolific and imaginative studies of somatic recombination in the immune system, detailing in molecular terms the genetics of antibody diversity. |
1987 | Massachusetts Institute of Technology | Basic Medical Research Award | For brilliantly demonstrating that the DNA responsible for antibody production is routinely reshuffled to create new genes during the lifetime of an individual. |
1987 | Harvard Medical School, Department of Genetics | Basic Medical Research Award | For his elegant genetic studies, particularly in carcinogenesis, and for developing transgenic laboratory animals for the study of cancer and other diseases. |
1987 | | Special Public Health Award (centennial, leadership in biomedical research) | For 100 years of leadership in biomedical research, establishing the pre-eminence of the United States in the fight against death, disease and disability. |
1986 | Vanderbilt University School of Medicine, Department of Biochemistry | Basic Medical Research Award | For discovering and biochemically defining epidermal growth factor (EGF), which illuminated the dynamics of cell growth. |
1986 | Harvard School of Public Health, Department of Immunology and Infectious Diseases | Clinical Medical Research Award | For his creative research on the impact of retroviral infection on the human immune system. |
1986 | Institute of Cell Biology | Basic Medical Research Award | For her original concept that cell growth is governed by soluble substances, and for the discovery of nerve growth factor (NGF). |
1986 | NIH | Clinical Medical Research Award | For determining that the retrovirus now known as HIV-1 is the cause of acquired immune deficiency syndrome (AIDS). |
1985 | University of Texas Southwestern Medical Center (The University of Texas Health Science Center at Dallas) | Basic Medical Research Award | Dupe? |
1985 | UT Southwestern Medical Center, Department of Molecular Genetics | Basic Medical Research Award | For their historic discovery of the basic mechanisms controlling cholesterol metabolism, opening the way to a new pharmacologic approach to the treatment of cardiovascular disease, the leading cause of death and disability in the Western world. |
1985 | University of Pittsburgh School of Medicine | Clinical Medical Research Award | For his profound influence in shaping the character of modern breast cancer treatment, thus lengthening and enriching the lives of women suffering from this dread disease |
1985 | University of Texas Health Science Center at Dallas, Department of Molecular Genetics | Basic Medical Research Award | For their historic discovery of the basic mechanisms controlling cholesterol metabolism, opening the way to a new pharmacologic approach to the treatment of cardiovascular disease, the leading cause of death and disability in the Western world. |
1984 | State University of New York at Stony Brook (SUNY) | Clinical Medical Research Award | For his theoretical and technical contributions which made possible a new form of medical imaging based on nuclear magnetic resonance. |
1984 | NIH | Basic Medical Research Award | For his fundamental research into the genetics of immunoglobulin molecules, paving the way for the development of hybridomas. |
1983 | Columbia University, Department of Neuroscience | Basic Medical Research Award | For his brilliant application of cell biology techniques to the study of behavior, revealing the mechanisms underlying learning and memory. |
1983 | New York University | Public Service Award | For his persistent leadership in conceiving, developing and testing vaccines against various viral diseases, especially hepatitis B, with vast impact on world health. |
1983 | Johns Hopkins University School of Medicine | Basic Medical Research Award | For his original discoveries which illuminate the brain's ability to perceive and organize information, and to translate sensory impulses into behavior. |
1982 | UCSF Department of Biochemistry and Biophysics | Basic Medical Research Award | For his elegant elucidation of the nature of oncogenes, and his contribution to the discovery that these genes are present in normal cells. |
1982 | Harvard University Medical School | Basic Medical Research Award | For his contributions to the first identification and functional characterization of the protein products of oncogenes, thus providing a clearer understanding of cell growth and regulation |
1982 | NIH | Basic Medical Research Award | For his pioneering studies that led to the discovery of the first human RNA tumor virus and its association with certain leukemias and lymphomas |
1982 | Rockefeller University | Basic Medical Research Award | For demonstrating how RNA tumor viruses cause cancer, and elucidating their role in combining, rescuing and maintaining oncogenes in the viral genome. |
1982 | NIH | Clinical Medical Research Award | For his pioneering contribution to the understanding of hereditary diseases, the development of effective genetic counseling procedures, and initiation of possible treatment by replacement of missing enzymes. |
1982 | NIH | Clinical Medical Research Award | For clarifying the molecular basis and diagnosis of certain hereditary lysosomal storage disorders that may cause growth abnormalities, mental retardation, blindness, deafness and death. |
1982 | NIH | Basic Medical Research Award | For his creative and successful pursuit toward the identification of the cellular oncogenes and their control. |
1981 | NIH | Clinical Medical Research Award | For developing a pioneering method which enables scientists to visualize the simultaneous biochemical activity of an entire network of neural pathways in the brain and central nervous system. |
1980 | Stanford University School of Medicine, Department of Biochemistry | Basic Medical Research Award | For his key, historic achievements which made recombinant DNA a brilliant reality, and inaugurated a new age of biomedical promise. |
1980 | UCSF School of Medicine, Department of Biochemistry & Biophysics | Basic Medical Research Award | For his brilliant contributions to recombinant DNA methodology, particularly in enzymology, plasmids, and in application of synthetic DNA. |
1980 | Stanford School of Medicine, Department of Genetics | Basic Medical Research Award | For his splendid contributions to recombinant DNA methodology, and for accomplishing the first transplantation of genes between cells. |
1980 | Columbia University College of Physicians and Surgeons | Clinical Medical Research Award | For his vital clinical research in developing an anti-Rh vaccine, which promises the conquest of hemolytic disease of the newborn. |
1980 | Stanford University School of Medicine, Department of Biochemistry | Basic Medical Research Award | For his crucial role in creating recombinant DNA methodology through his pathbreaking studies of cohesive single-stranded DNA. |
1980 | | Special Public Health Award | Presented to the NHLBI for its Hypertension Detection and Follow-Up Program, standing alone among clinical studies in its profound potential benefits to millions |
1979 | Harvard University | Basic Medical Research Award | For their brilliant development of a new technique for the rapid sequencing of DNA. |
1978 | University of Pennsylvania School of Medicine | Clinical Medical Research Award | For his perseverance in the development and clear demonstration of the efficacy of a purified vaccine of capsular polysaccharides in the prevention of pneumococcal diseases |
1978 | Cornell University- Weill Cornell Medical College (Cornell University Medical College) | Public Service Award | For implementing in 1972 the National High Blood Pressure Education Program, which has contributed significantly to the reduction in deaths from stroke, kidney and heart diseases. |
1978 | Rockefeller University, Laboratory of Bacterial Pathogenesis | Clinical Medical Research Award | For his creative leadership in developing, and then demonstrating the effectiveness of a purified capsular polysaccharide vaccine in preventing meningococcal diseases. |
1978 | University of Aberdeen | Basic Medical Research Award | For his pioneering work in identifying the relation of the opiate receptors to the naturally occurring enkephalins. |
1978 | Johns Hopkins University School of Medicine, Department of Neuroscience | Basic Medical Research Award | For his pioneering work in identifying the opiate receptors and the demonstration of their relation to the enkephalins. |
1976 | Georgia Health Sciences University Medical College of Georgia (Medical College of Georgia) | Clinical Medical Research Award | For his concept of alpha and beta receptors, which opened the door to the development of propranolol, a milestone drug in the treatment of heart diseases and severe high blood pressure. |
1976 | Veterans Administration; Mt. Sinai School of Medicine, City University of New York (CUNY) | Basic Medical Research Award | For the discovery and development of the technique of radioimmunoassay. |
1975 | Scripps Research Institute (Scripps Clinic and Research Foundation) | Basic Medical Research Award | For their outstanding contribution to the creation of a new medical discipline, immunopathology. |
1975 | Salk Institute for Biological Studies | Basic Medical Research Award | For research that has expanded our knowledge of the interplay between the hypothalamus and the endocrine system. |
1975 | Rockefeller University | Basic Medical Research Award | For their outstanding contribution to the creation of a new medical discipline, immunopathology. |
1974 | Columbia University College of Physicians and Surgeons | Basic Medical Research Award | For his contributions to molecular biology, including techniques of molecular hybridization and the first synthesis of an infectious nucleic acid. |
1974 | University of Wisconsin | Basic Medical Research Award | For his contributions to the biology of RNA-containing cancer viruses and elucidation of the mode of action of viral genes. |
1973 | Johns Hopkins University | Clinical Medical Research Award | For his life-saving development of open and closed chest defibrillators, and for originating the technique of external cardiac massage. |
1973 | Harvard Medical School; Beth Israel Hospital | Clinical Medical Research Award | For his development of the life-saving closed chest defibrillator and the pacemaker. |
1972 | Memorial Hospital for Cancer and Allied Diseases | Clinical Medical Research Award | For his outstanding contribution in recognizing the importance of Burkitt's tumor as a model. |
1972 | Mercy Catholic Medical Center | Clinical Medical Research Award | For his outstanding contribution in the supportive care, by platelet transfusion, of patients receiving intensive chemotherapy. |
1972 | Roswell Park Cancer Institute (Roswell Park Memorial Institute) | Clinical Medical Research Award | For his outstanding contribution in the treatment of premalignant and malignant cancers of the skin. |
1972 | St. Jude Children's Research Hospital | Clinical Medical Research Award | For their outstanding contribution to the concept and application of combination therapy in the treatment of acute leukemia in children. |
1972 | NIH | Clinical Medical Research Award | For their outstanding contribution to the successful chemotherapeutic treatment of gestational choriocarcinoma. |
1972 | NIH | Clinical Medical Research Award | For his outstanding contribution to advances in the concept of combination therapy in the treatment of acute leukemia in children. |
1972 | NIH (Yale University School of Medicine) | Clinical Medical Research Award | For his outstanding contribution to the concept of combination therapy in the treatment of Hodgkin's disease. |
1972 | University of Texas M.D. Anderson Cancer Center, Adult Leukemia Research Program | Clinical Medical Research Award | For his outstanding contributions in combination chemotherapy, and in supportive care of patients receiving combination chemotherapy for acute leukemia. |
1972 | | Clinical Medical Research Award | For their outstanding contribution to the successful chemotherapeutic treatment of gestational choriocarcinoma. |
1972 | Temple University | Clinical Medical Research Award | For his outstanding contribution to the concept of topical chemotherapy in the treatment of mycosis fungoides. |
1972 | NIH | Clinical Medical Research Award | For his outstanding contribution in increasing the cure rate of Burkitt's tumor by chemotherapy. |
1972 | NIH | Clinical (also listed as a Special Award) | Special Award: For his leadership in expanding the frontiers of cancer chemotherapy. |
1972 | Dana-Farber Cancer Institute (Children's Cancer Research Foundation) | Clinical Medical Research Award | For his outstanding contribution in the application of the concept of combination chemotherapy to lymphoma and acute adult leukemia. |
1972 | Roswell Park Cancer Institute (Roswell Park Memorial Institute) | Clinical Medical Research Award | For their outstanding contribution to the concept and application of combination therapy in the treatment of acute leukemia in children. |
1971 | California Institute of Technology | Basic Medical Research Award | For the brilliant contribution to molecular genetics. |
1971 | Stanford University, Department of Biology | Basic Medical Research Award | For their brilliant contribution to molecular genetics. |
1970 | University of Minnesota | Clinical Medical Research Award | For his uniquely important contributions to our understanding of the mechanism of immunity. |
1970 | Vanderbilt University School of Medicine (Vanderbilt University Medical School) | Basic Medical Research Award | For his discovery of cyclic AMP, and for providing a comprehension of this key chemical mechanism, which regulates hormonal action. |
1969 | Brookhaven National Laboratory | Clinical Medical Research Award | For his demonstration of the effectiveness of large daily dosages of L-DOPA in the treatment of Parkinson's disease. |
1968 | NIH | Basic Medical Research Award | For their contributions toward deciphering the genetic code. |
1968 | New York University Lagone Medical Center (New York University Medical Center) | Basic Medical Research Award | For his basic discoveries in the field of developmental biology. |
1967 | NIH | Basic Medical Research Award | For his extraordinary contributions to biochemical pharmacology. |
1966 | Dana-Farber Caner Institute (Children's Cancer Research Foundation); Children's Hospital Boston (Harvard Medical School at the Children's Hospital) | Clinical Medical Research Award | For his original use of aminopterin and methotrexate in the control of acute childhood leukemia, and for his constant leadership in the search for chemical agents against cancer. |
1966 | Rockefeller University | Basic Medical Research Award | For his fundamental contributions to the electron microscopy of biological materials. |
1965 | Cornell University | Basic Medical Research Award | For determining for the first time the chemical structure of an amino acid transfer RNA. |
1965 | University of Cincinnati College of Medicine | Clinical Medical Research Award | For the development of a live, oral poliovirus vaccine. |
1964 | Salk Institute of Biological Studies | Basic Medical Research Award | For their fundamental contributions to our knowledge of the relationship between cancer and cancer-producing DNA and RNA viruses. |
1964 | Rockland Psychiatric Center (Rockland State Hospital) | Clinical Medical Research Award | For the introduction and use of iproniazid in the treatment of severe depression. |
1964 | University of California, Berkeley, Department of Molecular & Cell Biology (Harvard Medical School, Mass. General Hospital, Department of Genetics?) | Basic Medical Research Award | For their fundamental contributions to our knowledge of the relationship between cancer and cancer-producing DNA and RNA viruses. |
1963 | Rockefeller University (Rockefeller Institute) | Basic Medical Research Award | For his countercurrent distribution technique as a method for the separation of biologically significant compounds, and for isolation and structure studies of important antibiotics. |
1963 | Baylor University College of Medicine | Clinical Medical Research Award | For his brilliant leadership and professional accomplishments, which were responsible in a large measure for inaugurating a new era in cardiovascular surgery. |
1963 | University of Chicago | Clinical Medical Research Award | For his role as a catalyst in modern endocrine studies of tumor control in animals and men. |
1962 | University of California, Berkeley | Basic Medical Research Award | For outstanding contributions to our understanding of the chemistry of pituitary hormones, including the identification and isolation of six hormones of the anterior pituitary gland. |
1962 | NIH | Clinical Medical Research Award | For outstanding contributions to the understanding, diagnosis, and treatment of virus and rickettsial diseases, including the demonstration of the efficacy of chloramphenicol as a cure for rickettsial infections—typhoid fever and epidemic and scrub typhus |
1960 | University of Michigan | Basic Medical Research Award | For his work on thalassemia and sickle cell anemia. |
1960 | Cold Spring Harbor Laboratory (Harvard University) | Basic Medical Research Award | For their contribution in revealing the structure of the DNA model. |
1959 | Harvard Medical School | Basic Medical Research Award | For his contributions in immunology and specifically for his development of the fluorescent method of labelling proteins, a significant tool for the study of infection in human beings. |
1959 | NIH | Basic Medical Research Award | For new findings in the field of immunology and allergy which have strengthened immunization procedures against such diseases as tuberculosis, malaria, rabies and poliomyelitis. |
1958 | University of California, Berkeley | Basic Medical Research Award | Joint award for their part in the discovery of the fundamental role of nucleic acid in the reproduction of viruses and in the transmission of inherited characteristics. |
1958 | University of Colorado, Denver | Basic Medical Research Award | For development of original methods for pure culture of living mammalian cells as a basis for new research in their nutrition, growth, genetics and mutation. |
1958 | Boston University School of Medicine | Clinical Medical Research Award | For distinguished contributions to the control of heart and blood vessel diseases through outstanding investigations into the causes, diagnosis and treatment of hypertension |
1957 | Douglas Hospital, Montréal | Clinical medical Research Award | For his demonstrations of the clinical uses of chlorpromazine in the treatment of mental disorders. |
1957 | University of Pennsylvania School of Medicine | Basic Medical Research Award | For fundamental contributions to knowledge of the heart and the circulation, and for his development of the first practical ballistocardiograph. |
1957 | National Institutes of Health | Public Service Award | For his unique contributions in laying the foundation for a national program of medical research and training. |
1956 | Johns Hopkins University | Clinical Medical Research Award | For his original, well-controlled studies in the cause and prevention of retrolental fibroplasia. |
1956 | University of Pittsburgh | Clinical Medical Research Award | For developing a safe and effective vaccine against poliomyelitis. |
1956 | Massachusetts Institute of Technology (MIT) | Basic Medical Research Award | Joint award for pioneering studies of the biochemical components of connective tissues, contributing to new understanding of arthritis and rheumatic diseases. |
1955 | University of Minnesota | Clinical Medical Research Award | Joint award for advances in cardiac surgery, making possible more direct and safer approaches to the heart. |
1954 | Tufts University School of Medicine (Tufts Medical College) | Basic Medical Research Award | For basic contributions to our knowledge of endocrine function, leading to the control of hyperthyroidism. |
1954 | Harvard Medical School | Basic Medical Research Award | For his achievements in the cultivation of the viruses of poliomyelitis, mumps and measles. |
1954 | Johns Hopkins University | Clinical Medical Research Award | Joint award for distinguished contributions to cardiovascular surgery and knowledge. |
1953 | University of Sheffield | Basic Medical Research Award | For his work as discoverer of the urea and citric acid cycles, which are basic to our understanding of how the body converts food into energy. |
1953 | Harvard University | Basic Medical Research Award | For his outstanding achievements in explaining the physiology of vision in man. |
1953 | | Group Award | For outstanding administration of a research grants program. |
1953 | NIH | Clinical Medical Research Award | For distinguished achievement in the pathology, diagnosis and treatment of heart disease. |
1952 | NIH | Clinical Medical Research Award | Joint award for leadership in the development of community-wide fluoridation programs. |
1949 | New York University | Basic Medical Research Award | Joint award for the discovery and purification of the enzymes streptokinase and streptodornase. |
1948 | Cornell University – Weill Cornell Medical College (Cornell University Medical College) | Basic Medical Research Award | For his basic studies of transmethylation as essential to animal nutrition; for his contributions to the structure and synthesis of biotin and penicillin. |
1948 | Rockefeller University (Rockefeller Institute for Medical Research) | Basic Medical Research Award | Joint award for their achievement in studies of the antibiotic properties of soil bacteria; Dr. Waksman was also cited for his discovery of streptomycin. |
1948 | NIH | Public Service Award | For his scientific accomplishments in the field of microbiological research and for his distinguished service as Director of the National Institutes of Health during the war and post-war years. |
1946 | | Group Award | In recognition of its fundamental contributions to the prevention and control of disease. |
This page last reviewed on September 28, 2022
Connect with Us
- More Social Media from NIH
- You are here:
- American Chemical Society
- Funding & Awards
ACS Award for Research at an Undergraduate Institution
Award at a glance.
To recognize the importance of research with undergraduates. The award will honor a chemistry faculty member whose research in an undergraduate setting has achieved wide recognition and contributed significantly to chemistry and to the professional development of undergraduate students.
Description
The award consists of $5,000 and a certificate. Up to $2,500 for travel expenses to the meeting at which the award will be presented will be reimbursed. Research Corp. will also provide a grant of $5,000 directly to the recipient's institution. .
Eligibility
The nominee's department may offer work leading to the master's degree but cannot have a doctoral program. This award recognizes fundamental research that constitutes advances in science as evidenced by refereed publications with undergraduate coauthors in leading scientific research journals, external research grant support, and the subsequent professional development of students who have participated in the research program. The award will be given for significant work over a long period of time rather than for a specific, limited project. A nominee must be a tenured faculty member of a predominantly undergraduate institution. The award will be granted regardless of race, gender, age, religion, ethnicity, nationality, sexual orientation, gender expression, gender identity, presence of disabilities, and educational background.
November 1 (Annual Review)
How to Apply
The nomination period is open from July 1 to November 1 annually. Learn more about submitting a nomination for the ACS National Awards .
Sponsored by Research Corporation for Science Advancement
Research Corporation for Science Advancement, a private foundation for the advancement of science, established the award in 1984.
ACS National Awards Program American Chemical Society 1155 16th Street NW | Washington, DC 20036 Email: awards@acs.org
Related Opportunities
Peter Debye Award in Physical Chemistry Encouraging and rewarding outstanding research in physical chemistry.
Frederic Stanley Kipping Award in Silicon Chemistry Recognizing distinguished contributions to the field of silicon chemistry and stimulating the creativity of others by example.
ACS Award for Affordable Green Chemistry Recognizing outstanding, cost-efficient scientific discoveries that lay the foundation for environmentally-friendly products or manufacturing processes.
ACS Award in Organometallic Chemistry Recognizing a recent advancement that is having a major impact on research in organometallic chemistry.
Accept & Close The ACS takes your privacy seriously as it relates to cookies. We use cookies to remember users, better understand ways to serve them, improve our value proposition, and optimize their experience. Learn more about managing your cookies at Cookies Policy .
1155 Sixteenth Street, NW, Washington, DC 20036, USA | service@acs.org | 1-800-333-9511 (US and Canada) | 614-447-3776 (outside North America)
- Terms of Use
- Accessibility
Copyright © 2024 American Chemical Society
Award for inclusion research program
The Award for Inclusion Research Program recognizes and supports academic research in computing and technology that addresses the needs of historically marginalized groups globally.
Launched in 2020, the Award for Inclusion Research (AIR) Program is an ongoing effort to support innovative research and professors working to create positive societal impact.
Program details
Application status, research areas, award details, eligibility criteria, review criteria, award recipients, applications are currently closed..
Decisions for the 2023 application cycle have been announced. Please check back for details on future application cycles.
Accessibility
Accessibility research is critical in its opportunity to advance inclusive technology that can enable and improve access for diverse user populations. Google's mission to "Organize the world's information and make it universally accessible and useful emphasizes the importance of accessibility at the company-level. Google works on a broad range of topics in accessibility to ensure that our technology is accessible and that it empowers people with disabilities to be socially engaged, productive, and independent. We are committed to research that advances the state-of-the-art in usable, useful, inclusive, and accessible technology.
Google strives for broad inclusion through support for assistive technologies, and research and development that aid people with vision, hearing, speech, motor, and/or cognitive disabilities.
For our program, we call for proposals specifically in the areas of:
- Wearable computing and augmentative technology
- Inclusive remote communication and telepresence to aid in collaboration among people with and without disabilities
- Transportation and mobility
- Tools and techniques for cognitive inclusion
Collaboration
Collaboration is responsible for far-reaching advances in computing. For example, such collaboration can occur in online communities like Wikipedia, open source software development projects, or teams of information workers in companies. Diverse and inclusive collaborations can create technology and products that are more inclusive of all users.
- Collaboration strategies to ensure that technological solutions meet the needs of a diverse set of users
- Scalable and repeatable interventions to help avoid technological solutions that might cause harm to historically marginalized and underserved communities
- Mitigating bias among collaborative teams
- Increasing belonging in collaborative teams
Collective & society-centered AI
Collective & society-centered AI research at Google builds upon traditions of multidisciplinary research. A community-collaborative approach actively involves impacted stakeholders throughout the application, system, or service design process to ensure their needs are met and can lead to AI systems that have a higher potential to benefit the community. The hallmark of these projects is that these will involve at least two stakeholder groups collaborating. Stakeholder groups include: researchers, developers, creators, end-users, community organizations, governments, citizens, and others.
- AI innovations for societal needs: transparency, work, education, collaboration, safety, quality, human-machine collaboration. Impact on creative community & regulation.
- AI integration with society: sociotechnical investigations of adoption, data, attitudes, responsible AI, & marginalized communities.
- AI development lifecycle: novel tools, infrastructure, and methods for collaboration, governance, and impact assessment.
Impact of AI on education
As we look towards the future of computing education, artificial intelligence (AI) is set to transform learning, teaching and assessment. At Google, we are committed to ensuring that the benefits of new technologies are universally accessible and useful. Given the current inequities in the computing education ecosystem, it is critical to support academic research on how and to what extent AI will impact computing in primary, secondary and higher education (at a systems-level) and pedagogical innovation.
- Examination of system-level effects of generative AI on K-16 computing education.
- Investigation of the effects of generative AI tools on pedagogy and learning, both opportunities and risks.
- Assessment of scalable models of educator professional development that incorporate generative AI tools.
- Exploration of foundational skills and knowledge students will need in computing education enabled by generative AI tools.
We encourage submissions from professors globally who are teaching at universities and meet the eligibility requirements. The AIR Program funds topics including accessibility, impact of AI on education, collaboration, collective & society-centered AI and gender bias, and many other areas that aim to have a positive impact on underrepresented groups.
- The funds granted will be up to $60,000 USD and are intended to support the advancement of the professor’s research during the academic year in which the award is provided.
- Awards are disbursed as unrestricted gifts to the university and are not intended for overhead or indirect costs.
- Open to professors (assistant, associate, etc) at a university or degree-granting research institution.
- Applicant may only serve as Principal Investigator (PI) or co-PI on one proposal per round. There can be a maximum of 2 PIs per proposal.
- Proposals must be related to computing or technology.
- Proposed research must impact users from historically marginalized groups. The definition of who is historically marginalized is responsive to a specific region, context, and its nuances; the proposal should define the users from historically marginalized groups the research aims to impact, and how the research will address their needs.
Strong proposals demonstrate a clear understanding of the users from historically marginalized groups the research aims to impact, such as direct collaboration with the users in the research process, describing the relationship of the PI(s) to the users/research, and describing the motivation to pursue the research.
Faculty merit
What is your prior research work? Are you qualified through your prior research experience to conduct the proposed research? Have you done preliminary research to show your investment in this space?
Broader impact & research merit
What is the impact of this research work being done successfully? Is it innovative? Could it change the academic landscape if successful? Do you have resources to conduct the research at hand?
Proposal quality
Is the proposal clear, focused and follows guidelines? Is it easy to navigate and how do you plan to approach the research problem? Do you provide further documentation as needed?
I am employed full-time at a university, but I am not a professor. Can I apply?
The program is open to active professors at degree-granting institutions who are advising students and conducting research.
What is the proper format for an Award for Inclusion Research proposal?
Below is an example of what a proposal may look like (though the relative length of each section may differ by proposal). The full proposal should be a maximum of 5 pages:
- [Maximum 3 Pages] The proposal overview, proposal body, and data policy.
- [Maximum 2 Pages] The CV of the primary Principal Investigator, which is required for all applications.
We would prefer proposals to respect a minimum 10pt font size and 1-inch (2.5-cm) margins. Our reviewers value readability.
- Proposal Title
- Principal Investigator full name, contact information (postal address, email address, phone), affiliation (university, school, college and/or department)
- Research goals and problem statement
- Description of the work you'd like to do, and expected outcomes and results.
- How will your research impact an underrepresented group?
- How does your research relate to prior work in the area (including your own, if relevant)? What makes you qualified to do this research work?
- References, where applicable.
- Our goal is to support work where the output will be made available to the broader research community. To that end, we ask that you provide us with a few sentences sharing what you intend to do with the output of your project (e.g. open sourcing code, making data sets public, etc.). Please note that the awards are structured as unrestricted gifts, so there are no legal requirements once a project is selected for funding. This is simply a statement of your current intentions.
- We require a CV for at least the primary Principal Investigator on the proposal. We will accept CVs from each of the Principal Investigators listed on the proposal (up to two are allowed). Each CV must be limited to two pages. Any submitted CV that is longer than 2 pages may be cut off at 2 pages before the proposal review process begins.
Please do not add a budget section on your proposal since it will not be considered.
Can I submit a proposal outside of the featured research areas on the main webpage?
Yes, we have a miscellaneous area in the application. Feel free to submit a proposal in any research area, in computing and technology, that addresses the needs of historically marginalized groups globally.
Does the co-PI need to meet the same eligibility criteria as the primary PI?
Yes, the co-PI must meet the same eligibility criteria as the primary PI. We are providing an exception if the co-PI is a postdoctoral researcher.
Can I submit a proposal around pre college research efforts?
No, proposals should only be focused on higher education.
Can I submit a proposal around funding a larger program?
This is not applicable for the AIR program unless the proposal studies the efficacy and applies research to the larger program.
Open advice to Google Research Awards proposal writers
As a part of the group of engineers that review proposals for this program, we read a lot of proposals. We'd like to read more good proposals. Here's some advice on how you can improve the content of your short proposal and make reviewing it easier.
A good research grant proposal:
Clearly specifies a problem. Good research is driven by a great problem or question, and a good proposal starts with a clearly specified one.
- Describes a specific, credible, relevant outcome. Try to identify a specific and appropriately sized outcome, to give us a clear notion of what the research award would be enabling. What will likely come to be that might otherwise not happen? While this outcome should be a decisive step towards achieving your vision, it generally won't be adequate to completely achieve it. It often helps to describe both the minimum that is likely to be accomplished and a potential best-case. Since picking the right datasets and test cases is often important, tell us which ones you plan to use.
- Crisply differentiates the proposed contribution from prior work. Please apply normal practices (citations, etc.) for documenting how your work will materially advance the state of the art. Make it clear how your work will be changing the state of the art, and not simply trying to match it.
- Tells us how the research challenge(s) will be addressed. Successful research projects combine a great problem with ideas for solutions, too. We recognize that all the answers won't be known yet, but we'd like to feel that the direction has been established, and a plausible path has been identified. (Try to avoid proposals of the form "We want to look at problem X".) It's hard to have a big impact without taking risks, but please identify what the difficulties are likely to be and how you plan to mitigate them. It may help to explain how you succeeded in addressing analogous problems in other projects.
- Puts the proposed work in context. Most projects we fund also have support from other sources. To help us understand the expected impact of Google support, please explain what funding you already have for this area of research and how the proposed work relates to your existing plans. Do you plan to build a capability for other research, provide a tool, reproduce a prior result, collaborate with others to try something out, follow up on a promising idea, or explore a new one? All are potentially of interest; we just want to know.
- Makes the case to a non-expert. While we try to have your proposal reviewed by a Google expert in your field, it will also be read by non-experts, so please make at least the motivation and outcomes broadly accessible.
- Tells us how this research impacts an underserved community and why you are qualified to do this research. It can be through social, cultural, or regional expertise, specifically related to the research to conduct successful work.
- The proposal should show promise that it will benefit society or advance desired societal outcomes.
See past Award for Inclusion Research recipients
Discover our collection of tools and resources
Browse our library of open source projects, public datasets, APIs and more to find the tools you need to tackle your next challenge or fuel your next breakthrough.
Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Home > Cancer Researchers / Other Health Care Professionals > Meetings > Meetings and Workshops Calendar > AACR Annual Meeting 2023 > AACR Scientific Achievement Awards, Lectureships, and Prizes
- Meeting Overview
- AACR Annual Meeting 2023: News and Highlights
- AACR Annual Meeting News
- Meeting Resources
- Program Changes
- AACR Runners for Research 5K Run/Walk
- Schedule at a Glance
- Spotlight on Clinical Trials
- Continuing Medical Education
- NextGen Stars
AACR Scientific Achievement Awards, Lectureships, and Prizes
- Satellite Educational Symposia
- AACR Annual Meeting 2025
- AACR Annual Meeting 2024
- Previous AACR Meetings: 2024
- Previous AACR Meetings: 2023
- Previous AACR Meetings: 2022
- Meetings and Workshops Calendar
- myAACR Support: Virtual Meeting Access / Registration
- Future Annual Meetings
- AACR Travel Grants
- Scholar-in-Training Awards: Annual Meeting
- Global Scholar-in-Training Awards
- Women in Cancer Research Scholar Awards
- AACR Minority Scholar in Cancer Research Awards
- AACR Minority and Minority-serving Institution Faculty Scholar in Cancer Research Awards
- AACR Scholar-in-Training Awards: Other Conferences and Meetings
- AACR-Undergraduate Scholar Awards
- AACR Statement Regarding Venues for the AACR Annual Meeting and Other Conferences
- General Information and FAQs
- Announcements: Other Organizations
Since 1961, the AACR has been proud to recognize scientific excellence across the spectrum of basic, translational, clinical, and epidemiological cancer research through a robust collection of annual awards and lectureships that serve to honor laboratory researchers, physician-scientists, and population scientists who have made significant contributions to our understanding of the diagnosis, prevention, and treatment of cancer.
The following award recipients were honored during the AACR Annual Meeting:
- AACR Award for Lifetime Achievement in Cancer Research Recipient: Carl H. June News Release | Award Lecture Summary
- AACR Award for Outstanding Achievement in Basic Cancer Research Recipient: Kathryn E. Wellen News Release
- AACR Award for Outstanding Achievement in Blood Cancer Research Recipient: Riccardo Dalla-Favera News Release
- AACR Award for Outstanding Achievement in Chemistry in Cancer Research Recipient: Carolyn R. Bertozzi News Release
- AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research Recipient: Polly A. Newcomb News Release
- AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research Recipient: Arul M. Chinnaiyan News Release
- AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Recipient: Elizabeth M. Jaffee News Release | Award Lecture Summary
- AACR Team Science Award Recipients: African Caribbean Cancer Consortium Team News Release
- AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention Recipient: Patricia A. Ganz News Release
- AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology Recipient: E. John Wherry News Release
- AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research Recipient: M. Celeste Simon News Release
- AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research Recipient: Melissa M. Hudson News Release
- AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship Recipient: Selwyn M. Vickers News Release
- AACR-Princess Takamatsu Memorial Lectureship Recipient: Robert D. Schreiber News Release
- AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research Recipient: Olivier Delattre News Release
- AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research Recipient: Jun J. Yang News Release
- AACR-Women in Cancer Research Charlotte Friend Lectureship Recipient: Cory Abate-Shen News Release
- Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research Recipient: Tak W. Mak News Release
- AACR June L. Biedler Prize for Cancer Journalism Read the News Release for the complete list of Prize recipients
- Awards and Lectureships
- Scientific Achievement Awards and Lectureships
Research Recognition Awards
The university has developed a series of awards to recognize members of its research community whose work helps advance knowledge, solve challenging problems, create new products and enhance quality of life.
Research Staff Awards
- The U-M Office of the Vice President for Research has established awards to recognize excellence among research staff. Review the full list of awards and submit nominations online.
Research Faculty Awards
The U-M Office of the Vice President for Research has established three awards to recognize excellence among research faculty: the Collegiate Research Professorship Award , the Research Faculty Achievement Award and the Research Faculty Recognition Award .
2024 Faculty Awardees
The Office of the Vice President for Research will honor six research faculty members from across the University of Michigan for their significant contributions and leadership in fields ranging from firearm injury prevention and multi-scale computation to Earth remote sensing and molecular imaging.
Alauddin Ahmed, Hugo Carreno-Luengo and Hsing-Fang Hsieh will receive the Research Faculty Recognition Award, while Jason Goldstick, Kathryn Luker and John Nees will receive the Research Faculty Achievement Award. All six will be recognized at the President’s Faculty Awards event this fall.
IJCAI Awards
IJCAI-24 Awards Announcement
The IJCAI-24 Award for Research Excellence, the John McCarthy Award and the Computers and Thought Award are awarded by the IJCAI Board of Trustees, upon recommendation by the IJCAI-24 Awards Selection Committee, which consists this year of
- Christian Bessiere,CNRS, Université Montpellier 2 LIRMM, FRANCE (Chair)
- Diego Calvanese, Free University of Bozen-Bolzano, ITALY
- Luc De Raedt, KU Leuven, BELGIUM
- Edith Elkind, University of Oxford, UK
- James Kwok, Hong Kong University of Science and Technology, Hong Kong, CHINA
- Zhi-Hua Zhou, Nanjing University, CHINA
The IJCAI Awards Selection Committee receives advice from members of the IJCAI-24 Awards Review Committee, who comment on the accuracy of the nomination material and provide additional information about the nominees. The IJCAI-24 Awards Review Committee is the union of the former Trustees of IJCAI, the IJCAI-24 Advisory Committee, the Program Chairs of the last three IJCAI conferences, and the past recipients of the IJCAI Award for Research Excellence and the IJCAI Distinguished Service Award, with nominees exclu
IJCAI-24 Award for Research Excellence:
The Research Excellence award is given to a scientist who has carried out a program of research of consistently high quality throughout an entire career yielding several substantial results. Past recipients of this honor are the most illustrious group of scientists from the field of Artificial Intelligence. They are: John McCarthy (1985), Allen Newell (1989), Marvin Minsky (1991), Raymond Reiter (1993), Herbert Simon (1995), Aravind Joshi (1997), Judea Pearl (1999), Donald Michie (2001), Nils Nilsson (2003), Geoffrey E. Hinton (2005), Alan Bundy (2007), Victor Lesser (2009), Robert Anthony Kowalski (2011), Hector Levesque (2013), Barbara Grosz (2015), Michael I. Jordan (2016), Andrew Barto (2017), Jitendra Malik (2018), Yoav Shoham (2019), Eugene Freuder (2020), Richard Sutton (2021), Stuart Russell (2022) and Sarit Kraus (2023).
The winner of the 2024 Award for Research Excellence is Thomas Dietterich , Distinguished Professor (Emeritus) and Director of Intelligent Systems, Institute for Collaborative Robotics and Intelligence Systems (CoRIS), Oregon State University, USA . Professor Dietterich is recognized for his pioneering work in machine learning, sequential decision-making, safe deployment of machine learning systems, applications to real-world problems in ecosystem management, and for his decades of intellectual leadership in machine learning.
IJCAI-24 Computers and Thought Award:
The Computers and Thought Award is presented at IJCAI conferences to outstanding young scientists in artificial intelligence. The award was established with royalties received from the book, Computers and Thought, edited by Edward Feigenbaum and Julian Feldman. It is currently supported by income from IJCAI funds. Past recipients of this honor have been: Terry Winograd (1971), Patrick Winston (1973), Chuck Rieger (1975), Douglas Lenat (1977), David Marr (1979), Gerald Sussman (1981), Tom Mitchell (1983), Hector Levesque (1985), Johan de Kleer (1987), Henry Kautz (1989), Rodney Brooks (1991), Martha Pollack (1991), Hiroaki Kitano (1993), Sarit Kraus (1995), Stuart Russell (1995), Leslie Kaelbling (1997), Nicholas Jennings (1999), Daphne Koller (2001), Tuomas Sandholm (2003), Peter Stone (2007), Carlos Guestrin (2009), Andrew Ng (2009),Vincent Conitzer (2011), Malte Helmert (2011), Kristen Grauman (2013), Ariel Procaccia (2015), Percy Liang (2016), Devi Parikh (2017), Stefano Ermon (2018), Guy Van den Broeck (2019), Piotr Skowron (2020), Fei Fang (2021), Bo Li (2022) and Pin-Yu Chen (2023).
The winner of the 2024 IJCAI Computers and Thought Award is Nisarg Shah , Associate Professor of Computer Science, University of Toronto, Canada. Dr. Shah is recognized for his contributions to AI and society, in particular foundational work on the theory of algorithmic fairness using principles from social choice theory.
IJCAI-24 John McCarthy Award:
The IJCAI John McCarthy Award is intended to recognize established mid-career researchers, typically between fifteen to twenty-five years after obtaining their PhD, that have built up a major track record of research excellence in artificial intelligence. Nominees of the award will have made significant contributions to the research agenda in their area and will have a first-rate profile of influential research results. The award is named for John McCarthy (1927-2011), who is widely recognized as one of the founders of the field of artificial intelligence. As well as giving the discipline its name, McCarthy made fundamental contributions of lasting importance to computer science in general and artificial intelligence in particular, including time-sharing operating systems, the LISP programming languages, knowledge representation, common-sense reasoning, and the logicist paradigm in artificial intelligence. The award was established with the full support and encouragement of the McCarthy family. Past recipients of this honor have been: Bart Selman (2015), Moshe Tennenholtz (2016), Dan Roth (2017), Milind Tambe (2018), Pedro Domingos (2019), Daniela Rus (2020), Tuomas Sandholm (2021), Michael L. Littman (2022) and Dieter Fox (2023).
The winner of the 2024 John McCarthy Award is David Blei , Professor of Statistics and Computer Science, Columbia University, USA. Professor Blei is recognized for his groundbreaking work in machine learning, in particular his field-defining contributions in the areas of topic models and stochastic variational inference.
Donald E. Walker Distinguished Service Award:
The IJCAI Distinguished Service Award was established in 1979 by the IJCAI Trustees to honor senior scientists in AI for contributions and service to the field during their careers. Previous recipients have been: Bernard Meltzer (1979), Arthur Samuel (1983), Donald Walker (1989), Woodrow Bledsoe (1991), Daniel G. Bobrow (1993), Wolfgang Bibel (1999), Barbara Grosz (2001), Alan Bundy (2003), Raj Reddy (2005), Ronald J. Brachman (2007), Luigia Carlucci Aiello (2009), Raymond C. Perrault (2011), Wolfgang Wahlster (2013), Anthony G. Cohn (2015), Erik Sandewall (2016), Ramon Lopez de Mantaras (2017), Craig Knoblock (2018), Francesca Rossi (2019), Toby Walsh (2020), Steven Minton (2021), Bernhard Nebel (2022) and Qiang Yang (2023).
2024 DSA Winner will be announced later in June 2024.
Copyright © 2024,
Website Navigation for Screen Readers
- Return home
- Go to header navigation
- Go to search form
- Go to content region
- Go to footer region
Johns Hopkins Discovery Awards: 2024 Awardees
In 2024, 44 Discovery Awards were given to interdisciplinary faculty teams across eleven units of Johns Hopkins.
The Discovery Awards encourage faculty from various disciplines to collaborate in addressing multifaceted challenges and pushing the boundaries of understanding. 2024 awarded projects will launch a wide range of inquiry – creating DNA-based hydrogel bioinks with enhanced mechanical properties for advanced 3D bioprinting applications, such as smart bandages, biosensors, and water filtration membranes, gaining a better understanding of how trust in the healthcare system is formed and how it influences patient behavior and outcomes, with the goal of identifying strategies to improve trust and, consequently, public health, and designing a novel influenza vaccine to overcome the challenges of immunosenescence and inflammaging in the elderly, which currently limit the effectiveness of seasonal influenza vaccines.
Altogether, the winning project teams—chosen from 286 proposals—include 148 individuals representing 11 Johns Hopkins entities.
3D-LAMMBS: Data-Driven, Deep Learning Architectures for Multiscale Modeling of Biological Systems – Michael Lapera (Applied Physics Lab), Melissa Yates (Applied Physics Lab), Vicky Nguyen (Engineering) & Somdatta Goswami (Engineering) *Co-Funded with the Data Science and AI Institute *
A Bone Marrow Targeting Vehicle for IL-15 to Enhance NK Cell Anti-leukemic Effect – Maxim Rosario (Medicine), Scott Wilson (Medicine) & Jay Bream (Public Health)
A Long-read-based, Epigenome-first Approach for Molecular Diagnosis – Carolina Montano (Engineering), Nara Sobreira (Medicine), Kasper Hansen (Public Health) & Winston Timp (Engineering)
Advancing Brain Tumor Immunotherapy Informed by Circulating Tumor Cell-Derived Membrane Fragments – Jelani Zarif (Medicine), Claire Hur (Engineering), David Kamson (Medicine) & Stavroula Sofou (Engineering)
Brain-wide Mapping of Astrocyte Activity Using Genetically Encoded Crystal Recorders (GECRs) – Dwight Bergles (Medicine) & Dingchang Lin (Engineering)
Characterizing the Acute Impact of Air Pollution Exposures on Blood Pressure and Implications for Clean Cooking – Kendra Williams (Public Health), Yvonne Commodore-Mensah (Nursing) & William Checkley (Medicine)
Climate Change-Proofing the US Healthcare System – Understanding and Cultivating Resilience to Climate-Driven Compound and Cascading Disasters – Crystal Watson (Public Health), Tara Kirk Sell (Public Health), Christopher Lemon (Medicine), Toner Eric (Public Health), Rob Carter (Medicine) & Jon Links (Public Health)
Cross-species Examination of Supporting Cell-to-progenitor Cell Fate Transitions During Hair Cell Regeneration – Erin Jimenez (Arts & Sciences) & Angelika Doetzlhofer (Medicine) *Co-Funded with the OneNeuro Initiative *
Data Valuation in Distributed and Private Large-Scale Radiology – Jeremias Sulam (Engineering), Harrison Bai (Medicine), Mahyar Fazlyab (Engineering) & Nicolas Loizou (Engineering)
Deep Learning Applications in ECG Analysis for Atrial Fibrillation Patients: A New Horizon in Diagnosis and Monitoring – Eugene Kholmovski (Engineering), Natalia Trayanova (Engineering), David Spragg (Medicine) & Yazan Mohsen (Engineering)
Developing a Framework to Address the Needs of Persons with Cancer Pain and Opioid Guidelines in the Age of the Opioid Epidemic – Sydney Dy (Public Health), Travis Rieder (Berman) & Julie Waldfogel (Medicine)
Developing Innovative Implementation Methods: Coastal Resilience Solutions for the Baltimore Area – Jennifer Boothby (Applied Physics Lab), Benjamin Zaitchik (Arts & Sciences) & Chris Overcash (Engineering)
DNA Bioinks for Next-Generation 3D Bioprinting – Angelo Cangialosi (Applied Physics Lab) & Rebecca Schulman (Engineering)
Eliminating Cataract-related Vision Loss Through a New, Artificial Intelligence-based Screening Modality – Kunal Parikh (Medicine), Nakul Shekhawat (Medicine), Rama Chellappa (Engineering/Medicine), Nathanael Kuo (Applied Physics Lab), Rai Munoz (Applied Physics Lab) & Jordan Shuff (Medicine)
Employing Lung Organoid Models to Test Carcinogenicity Associated with Electronic Cigarette Exposure (ELUCIDATE Study) – Michelle Vaz (Medicine) & Ana Rule (Public Health)
Estrogen Receptor Mutations as a Novel Biomarker in Gynecological Malignancies – Utthara Nayar (Public Health) & Stephanie Gaillard (Medicine)
Exploring the Neural Architecture of Psychedelic Experience with High-density Electrophysiology – Austin Graves (Engineering), Tim Harris (Engineering) & Kellie Tamashiro (Medicine)
Extracellular Vesicle (EV) RNA as Functional Biomarkers of Clinical ASD Heterogeneity – Lena Smirnova (Public Health), Sarven Sabunciyan (Medicine) & Constance Hicks-Smith (Medicine) *Co-Funded with the OneNeuro Initiative *
‘Feels Like Home’: Lived Experiences of Children with Medical Complexity and Their Families – Rebecca Seltzer (Medicine) & Lauren Arora Hutchinson (Berman)
Harnessing Single-Atom Plasmonic Catalysis for High-Efficiency Energy Transformations – Anthony Shoji Hall (Engineering) & Thomas Kempa (Arts & Sciences) *Co-Funded with the Ralph O’Connor Sustainable Energy Institute *
Health Education and Training (HEAT) Corps: Novel Strategy for Community Health in Schools through Community Health Workers – Panagis Galiatsatos (Medicine), Annette Anderson (Education), Catherine Ling (Nursing), Mindi Levin (Public Health) & Jennifer Ross (University Administration)
High-throughput Identification of Cell-state Induced Changes in Subcellular mRNA Localization in the Brain – Solange Brown (Medicine), Loyal Goff (Medicine), Genevieve Stein-O’Brien (Medicine) & Jean Fan (Engineering)
Identification of Molecular and Cellular Mechanisms Regulating Sleep Need Using Automated, Selective and Non-stressful Sleep Deprivation in larval Zebrafish – Seth Blackshaw (Medicine), Claire Hur (Engineering) & Mark Wu (Medicine) *Co-Funded with the OneNeuro Initiative *
Infrastructure Climate Adaptation/Resiliency in the US (ICARUS) – Marisel Villafane-Delgado (Applied Physics Lab), Yuri Dvorkin (Engineering), Dennice Gayme (Engineering), Enrique Mallada (Engineering), Rebecca Eager (Applied Physics Lab), Krista Rand (Applied Physics Lab), Jared Markowitz (Applied Physics Lab) & Valerie Washington (Applied Physics Lab) *Co-Funded with the Ralph O’Connor Sustainable Energy Institute *
Investigating Structural Bases for Active and Inactive Condensate Formation by Cyclic-G/AMP (cGAMP) Synthase (cGAS) – Jungsan Sohn (Medicine), Anthony Leung (Public Health) & Edward Twomey (Medicine)
Large Language Models for Knowledge Discovery in the Opioid Industry Documents Archive – Anjalie Field (Engineering), G. Caleb Alexander (Public Health) & Louis Hyman (KSAS) *Co-Funded with the Data Science and AI Institute *
Modeling the Dynamic Nucleocytoskeletal Interface in Cycling Cells – Karen Reddy (Medicine) & Sean Sun (Engineering)
NanoPorous Catalysts and Adsorbents for a Circular, Energy-Efficient, and Sustainable Silicone Economy – Michael Tsapatsis (Engineering), Rebekka Klausen (Arts & Sciences) & Brandon Bukowski (Engineering) *Co-Funded with the Ralph O’Connor Sustainable Energy Institute *
Non-invasive Imaging for Cardiovascular Evaluation – Austen Lefebvre (Medicine), Sung-Min Cho (Medicine), David Blodgett (Applied Physics Lab) & Nikki Steiner (Applied Physics Lab)
Novel Europium-Based Fluorination for Prostate Imaging – Laurence Carroll (Medicine) & Thomas Lectka (Arts & Sciences)
Novel Materials for Custom-Tuned Earplugs for Musicians: A Multifaceted Approach – Michael Kessler
(Engineering), Kris Chesky (Peabody/Medicine) & Gurumurthy Ramachandran (Public Health)
Pharmaceutical Market Dynamics and Competition: The Impact of New Drug Formulations on Marketing and Spending – Ravi Gupta (Medicine), Joseph Levy (Public Health) & Michael DiStefano (Public Health) *Co-Funded with the Hopkins Business of Health Initiative *
Plasmonic Probe and Control of Topological Magnetic States – Natalia Drichko (Arts & Sciences) & Susanna Thon (Engineering)
Preventing Blindness Using AI-enabled, Point-of-care Diagnosis of Corneal Infections – Nakul Shekhawat (Medicine), Kunal Parikh (Medicine), Rama Chellappa (Engineering/Medicine), Nathanael Kuo (Applied Physics Lab), Rai Munoz (Applied Physics Lab) & Jordan Shuff (Medicine)
Programmed Regenerative Inflammation for Functional Recovery in Repairing Volumetric Muscle Loss – Laszlo Nagy (Medicine), Hai-Quan Mao (Engineering) & Warren Grayson (Medicine)
Spatial Mapping of the Cortico-striatal-basal Ganglia Circuit Using Flexible Nonlinear Neural Probes – Dingchang Lin (Engineering) & Patricia Janak (Arts & Sciences)
Spatial Transcriptomics for the Clinical Setting: Capturing an Elusive Cell Population in a Rare Disease with Spatial Transcriptomics of Rosai-Dorfman Disease – Eugene Shenderov (Medicine), Ezra Baraban (Medicine) & Hongkai Ji (Public Health)
The Dynamics of Trust: An Interdisciplinary Approach to Improving Health Care Outcomes – Michael Darden (Business), Mario Macis (Business), Christina Yuan (Business), Kathy McDonald (Nursing/Medicine/Public Health/Business) & Mary Catherine Beach (Medicine)
The Impact of Sex-Dependent Glycosylation on Nitros(yl)ation in Myocardial Infarction – Natasha Zachara (Medicine), Brian Foster (Medicine), Mark Kohr (Public Health) & Priya Umapathi (Medicine)
The Neural Basis of Continual Learning in the Face of Early Life Adversity – Kishore Kuchibhotla (Arts & Sciences), Maya Opendak (Medicine), Adam Charles (Engineering) & Chris Honey (Arts & Sciences)
This IS Your Grandma’s Vaccine!: Engineering Immunity in the Elderly – Scott Wilson (Medicine) & Sabra Klein (Public Health)
Using Nanopore Sequencing of TET3-deficient Cells to Understand and Abrogate Disrupted DNA Methylation States in Human Neurons – Jill Fahrner (Medicine), Winston Timp (Engineering) & Kasper Hansen (Public Health)
Using the Low-Income Housing Tax Credit for Assisted Living? Mapping the Current Environment and Charting a Path Forward – Kali Thomas (Nursing) & Craig Pollack (Public Health) *Co-Funded with the Hopkins Business of Health Initiative *
Virtual Neurology Clinic: A Human-AI Interface for Remote Autonomous Augmented/Virtual Reality Neurologic Screening and Triaging – Kemar Green (Medicine), John Probasco (Medicine), Ayah Zirkly (Engineering), Ziang Xiao (Engineering), Vishal Patel (Engineering), Peter Kazanzides (Engineering) & Youseph Yazdi (Medicine) *Co-Funded with the Institute for Assured Autonomy *
Vice Provost for Research
265 Garland Hall 3400 North Charles Street Baltimore, MD 21218
(443) 927-1957
- External link to Twitter
- Research at Johns Hopkins
- Bloomberg Professors
- Awards Programs & Initiatives
- Research Development
- Research Administration
- © 2024 Johns Hopkins University
- University Contacts
- Emergency Contact Information
- University Policies and Statements
Website Footer Navigation
About the Foundation
- Leadership & Collaboration
- Financial Responsibility
- How to Help
- Ways to Give
- Honors and Memorials
- Award Programs
- Grant Selection Process
- Funded Grants
- Special Funds
- Researcher Resources (Password Required)
- Inspiration
- Team Science
- V Ambassadors
- Video & Podcasts
Events & Fundraisers
- Events & Fundraisers
- Events Calendar
- Signature Events
- Victory Ride
- Run For Team V
- Fundraise for the V
- Fundraising Friends
For Patients
The V Foundation for Cancer Research Announces 2024 Recipients for A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research
Fifteen women scientists were awarded research grants to advance their innovative work in the cancer field, helping to address the significant funding disparities for women in science.
Cary, NC (June 24, 2024) – The V Foundation for Cancer Research, a top-rated cancer charity, is proud to announce the second annual recipient class of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research . Fifteen exceptional women scientists were selected for their groundbreaking cancer research studies, with the V Foundation investing $10.2 million this year – and a total of $18.6 million since the program’s start in 2023.
This critical initiative is working to level the playing field for women in science, addressing the longstanding gender disparities in the research field. The breadth of challenges that women researchers face is substantial, including salary gaps and lower research funding than their male counterparts. Additionally, women are often tasked with a heavier distribution of parenting, household roles, caregiving and even workplace administrative duties, taking time away from work in the lab.
The V Foundation for Cancer Research established A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research with the goal of promoting equity within the science community. The organization also serves as a premier supporter of advancing woman-led laboratories, research projects and discoveries in the cancer research field.
“There is no question that game-changing cancer research requires the brightest minds in science and the recipients selected for A Grant of Her Own are exactly that,” said Susanna Greer, Ph.D., Chief Scientific Officer at the V Foundation. “This is such a valuable opportunity to drive forward the innovative research occurring in each of their laboratories while also highlighting the importance of creating an equitable and empowering space for women in science.”
The V Foundation awards grants through a highly-selective review process overseen by its Scientific Advisory Committee, a distinguished group of clinicians and scientists from top cancer centers across North America. Each research proposal is carefully reviewed, and grants are awarded to the most promising research projects and scientists that will lead to breakthrough discoveries and lifesaving treatments.
The grants will be distributed between Translational and V Scholar awards. Of the 15 researchers selected for A Grant of Her Own, six scientists will be awarded a Translational Grant, which funds “bench-to-bedside” research, often culminating in the planning or initiation of a clinical trial. Nine researchers will be awarded the V Scholar Grant, an investment in early career researchers with cutting-edge ideas.
The recipients of the Translational Research Award, each receiving $800,000 over four years, are:
- Gina Ogilvie, M.D., M.Sc., FCFP, Dr.PH., BC Cancer Research Centre: Developing new methods of cervical cancer screening with improved accuracy
- Livia S. Eberlin, Ph.D., Dan L Duncan Comprehensive Cancer Center: Transforming rectal cancer surgery with new technology to achieve complete cancer removal while preserving patient quality of life
- Josephine A. Taverna, M.D., Mays Cancer Center at UT Health San Antonio: Tailoring individual treatments for lung cancer patients based on the tumor’s unique traits
- Humsa Venkatesh, Ph.D., Brigham and Women’s Hospital: Uncovering how neuronal activity drives growth of brain tumors
- Andrea Cercek, M.D., Memorial Sloan Kettering Cancer Center: Evaluating immunotherapy use in a subset of rectal cancer patients to increase responses and decrease the need for radiation and surgery
- Maria T. Abreu, M.D., Sylvester Comprehensive Cancer Center: Targeting the gut microbiome for colorectal cancer treatment and prevention
The grantees of the V Scholar Award, each receiving $600,000 over three years, are:
- Melissa Reeves, Ph.D., Huntsman Cancer Institute: Exploring variability in the anti-tumor immune response in order to improve responses to immunotherapy
- Carla Nowosad, Ph.D., Laura and Isaac Perlmutter Cancer Center at NYU Langone Health: Tracking immune cells and antibodies and determining their contribution to colorectal cancer development and progression
- Esther Rheinbay, Ph.D., Massachusetts General Hospital: Defining the consequences of Y or X chromosome loss in uveal melanoma
- Jessica Stark, Ph.D., David H. Koch Institute for Integrative Cancer Research at MIT: Unlocking the potential of targeting sugars for colorectal cancer immunotherapy
- Noam Auslander, Ph.D., Ellen and Ronald Caplan Cancer Center of The Wistar Institute: Identifying biomarkers of immunotherapy benefit and adverse events in melanoma
- Christine Eyler, M.D., Ph.D., Duke Cancer Institute: Deciphering Drivers of Cell Changes in Response to Rectal Cancer Radiation
- Corina Antal, Ph.D., Moores Comprehensive Cancer Center: Uncovering novel vulnerabilities in pancreatic cancer to discover new therapeutic targets
- Caroline Bartman, Ph.D., Abramson Cancer Center: Targeting vitamin B1 metabolism to starve colorectal cancer
- Xueqiu (Chu) Lin, Ph.D., Fred Hutch Cancer Center: Mapping oncogenic gene regulatory networks for colorectal cancer risk prediction
“I am thrilled that my grant was selected for funding. I have admired the V Foundation for many years, and it is such an honor to now be one of the grantees. I am very thankful and looking forward to starting the research we proposed in rectal cancer,” said Livia S. Eberlin, Ph.D., a Translational Grant award recipient. “The research we propose could dramatically improve outcomes for patients undergoing surgery for rectal cancer by providing surgeons with a new molecular-based device that allows them to identify tissues in vivo with certainty before excision, therefore enabling full removal of the cancerous tissues while preserving normal adjacent tissue structures that are unaffected.”
For further information about A Grant of Her Own and other V Foundation grant programs, visit www.v.org .
About the V Foundation for Cancer Research
The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach and ESPN commentator. The V Foundation has funded over $353 million in game-changing cancer research grants nationwide through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations are awarded to cancer research and programs. The V team is committed to accelerating Victory Over Cancer®. To learn more, visit v.org.
Caroline Rebosio [email protected]
Alexandra Paterson [email protected]
Related Stories
The 20th annual dick vitale gala date announced, susanna’s cool cancer research finds: june 2024, from dream to reality (30+ years in the making), how funding investigators can change the trajectory of cancer treatment, popular tags.
- About Paul F. Glenn
- Glenn Centers
- Awards & Programs
- Bay Area Aging Meeting (BAAM)
- La Jolla Aging Meeting (LJAM)
- Harvard Paul F. Glenn Symposium on Aging
GLENN AWARDS
Glenn award recipients.
Titia de Lange, Ph.D. Rockefeller University
Allan Drummond, Ph.D. University of Chicago
Matthew Hirschey, Ph.D. Duke University
Isha Jain, Ph.D. University of California, San Francisco
Aimee Kao, M.D., Ph.D. University of California, San Francisco
Morgan Levine, Ph.D. Yale University
Geeta Narlikar, Ph.D. University of California, San Francisco
Evgeny Nudler, Ph.D. New York University
Jay Olshansky, Ph.D. University of Illinois Chicago
Patricia Opresko, Ph.D. University of Pittsburgh Cancer Institute
Amy Pasqinelli, Ph.D. University of California, San Diego
Charlotte Peterson, Ph.D. University of Kentucky
Peter Adams, Ph.D. SBP Medical Discovery Institute
Rajendra Apte, M.D., Ph.D. Washington University in St. Louis
Shelley Berger Ph.D. University of Pennsylvania
Clement Chow, Ph.D. University of Utah
Kristin Fortney, Ph.D. Bioage Labs
Elaine Fuchs, Ph.D. Rockefeller University
Ming Guo, M.D., Ph.D. University of California at Los Angeles
Valentina Greco, Ph.D. Yale University
Catherine Kaczorowski, Ph.D. The Jackson Laboratories
Louis Lapierre, Ph.D. Brown University
Jun Hee Lee, M.D., Ph.D. University of Michigan
Laura Niedernhofer, M.D., Ph.D. Scripps Research Institute
Alexander Soukas, M.D., Ph.D. Mass General Hospital
R. Luke Wiseman, Ph.D. Scripps Research Institute
Roberto Zoncu, Ph.D. University of California at Berkeley
Keith Blackwell, M.D., Ph.D. Joslin Diabetes Center
Dirk Bohmann, Ph.D. University of Rochester
Rachel Brem Ph.D. Buck Institute for Research on Aging
Christin Burd, Ph.D. Ohio State University
Stirling Churchman, Ph.D. Harvard Medical School
Vishwa Deep Dixit, D.V.M., Ph.D. Yale University
Peter Douglas, Ph.D. University of Texas Southwestern
Vadim Gladyshev, Ph.D. Brigham and Women’s Hospital
Peggy Goddell, Ph.D. Baylor College of Medicine
Adam Hughes, Ph.D. University of Utah
Nicholas Ingolia, Ph.D. University of California at Berkeley
Dan Jarosz Ph.D. Stanford
Shane Liddelow, Ph.D. Stanford University
Valter Longo, Ph.D. USC
Tomas Prolla, Ph.D. University of Wisconsin
Amita Sehgal, Ph.D. University of Pennsylvania
Nicholas Stroustrup, Ph.D. Harvard Medical School
Meng Wang, Ph.D. Baylor College of Medicine
Jan Vijg, Ph.D. Albert Einstein College of Medicine
Rozalyn Anderson University of Wisconsin
Steve Austad University of Alabama
Ben Barres Stanford
Helen Blau Stanford
Rolf Bodmer SBP Medical Discovery Institute
Nancy Bonini University of Pennsylvania
Shreekanth Chalasani Salk Institute
Fabio Demontis St. Jude Children’s Research Hospital
Sandra Encalada The Scripps Research Institute
Aaron Gitler Stanford University
Kim Green University of California, Irvine
Cole Haynes Memorial Sloan Kettering
Leanne Jones UCLA
Matt Kaeberlein University of Washington
Lauren Koch University of Michigan
Dudley Lamming University of Wisconsin
William Mair Harvard
David J. Marcinek University of Washington
Dana Miller University of Washington
Richard Morimoto Northwestern University
Raul Mostoslovsky Harvard
Bradley Olwin University of Colorado
Michael Petrascheck The Scripps Research Institute
Daniel Promislow University of Washington
Blanka Rogina University of Connecticut Health Center
Alessandra Sacco SBP Medical Discovery Institute
Beth Stevens Boston Children’s Hospital
Saul Villeda UCSF
David Walker UCLA
Ashley Webb Brown University
Tony Wyss-Coray Stanford
British Society for Research on Ageing UK (presented at the House of Lords)
Lynne S. Cox University of Oxford
Dena Dubal UCSF
Laura Dugan, M.D. Vanderbilt University
Walter Fontana Harvard University
Helen R. Griffiths Aston University, UK
Nathan LaBrasseur, Ph.D. Mayo Clinic
Michael Keiser, Ph.D. UCSF
David Kokel, Ph.D. UCSF
Hayley Lees University of Oxford
Susan Lindquist, Ph.D. Massachusetts Institute of Technology
Prof. Janet Lord University of Birmingham, UK
Prof. James Malone-Lee University College London
Sofiya Milman, M.D. Albert Einstein College of Medicine
Emmanuelle Passegué, Ph.D. UCSF
David Schaffer, Ph.D. UC Berkeley
David Berry, Ph.D. UCSF
Katrin Chua, Ph.D. Stanford
Mimi Cushman, Ph.D. UCSF
Jill Crandall, M.D. Albert Einstein College of Medicine
Michael Fischbach, Ph.D. UCSF
Jennifer Garrison, Ph.D. Buck Institute
Martin W. Hetzer, Ph.D. Salk Institute for Biological Studies
Dirk Hockemeyer, Ph.D. UC Berkeley
Richard T. Lee, M.D. Brigham and Women’s Hospital
Gordon Lithgow, Ph.D. Buck Institute
Simon Melov, Ph.D. Buck Institute
John Newman, M.D., Ph.D. University of California, San Francisco
Lior Pachter, Ph.D. UC Berkeley
Jan Stoehr, Ph.D. UCSF
Jonathan Wanagat, M.D., Ph.D. UCLA
Jeremy D. Walston, M.D. Johns Hopkins
Suzanne Wolff, Ph.D. UC Berkeley
Darren J. Baker, Ph.D. Mayo Clinic
Rafael de Cabo, Ph.D. National Institute on Aging
Judith Campisi, Ph.D. Buck Institute for Research on Aging
Danica Chen, Ph.D. University of California at Berkeley
Jan van Deursen, Ph.D. Mayo Clinic
Ari Gafni, Ph.D. The University of Michigan
Bradley Hyman, M.D., Ph.D. Massachusetts General Hospital
Donald K. Ingram, Ph.D. Pennington Biomedical Research Center
Cynthia Kenyon, Ph.D. UCSF
James L. Kirkland, M.D., Ph.D. Mayo Clinic
Edward Lakatta, M.D. National Institute on Aging
Mark P. Mattson, Ph.D. National Institute on Aging
Cynthia T. McMurray, Ph.D. Lawrence Berkeley National Laboratory
Charles Mobbs, Ph.D. Mount Sinai School of Medicine
Richard L. Sprott, Ph.D. International Healthspan Institute
Suzette D. Tardif, Ph.D. University of Texas Health Science Center
Jonathan L. Tilly, Ph.D. Massachusetts General Hospital
Woodring Wright, M.D., Ph.D. University of Texas Southwestern Medical Center
Paul H. Axelsen, M.D. University of Pennsylvania
Randall Bateman, M.D. Washington University School of Medicine
Holly M. Brown-Borg, Ph.D. University of North Dakota
Rochelle Buffenstein, Ph.D. University of Texas, San Antonio
Pinchas Cohen, M.D. University of California, Los Angeles
Ron DePinho, Ph.D. M.D. Anderson Cancer Center
Luigi Fontana, M.D. Washington University School of Medicine
Li Gan, Ph.D. Gladstone Institute for Neurological Disease
Malene Hansen, Ph.D. Sanford-Burnam Medical Research Institute
C. Ronald Kahn, M.D. Joslin Diabetes Center
David Karasik, Ph.D. Institute for Aging Research, Boston
Willis Li, Ph.D. University of California, San Diego
James R. Mitchell, Ph.D. Harvard School of Public Health
Salvatore Oddo, Ph.D. University of Texas, San Antonio
Carlos Orihuela, Ph.D. University of Texas, San Antonio
Dean Ornish, M.D. Preventive Medicine Research Institute
Dave Pagliarini, Ph.D. University of Wisconsin, Madison
Qito Ran, Ph.D. University of Texas, San Antonio
Rama Ranganathan, M.D., Ph.D. University of Texas Southwestern Medical Center
Randy Schekman, Ph.D. University of California, Berkeley
John Sedivy, Ph.D. Brown University
Gerald S. Shadel, Ph.D. Yale University School of Medicine
Suzette D. Tardif, Ph.D. University of Texas, San Antonio
Holly Van Remmen, Ph.D. University of Texas, San Antonio
Peter Walter, Ph.D. University of California, San Francisco
Stephen Artandi Stanford University
Richard Faragher University of Brighton, School of Pharmacy and Biomolecular Sciences
Vera Gorbunova University of Rochester, Biology Department
William Ja The Scripps Research Institute
Heinrich Jasper University of Rochester, Biology Department
Brian Kennedy Buck Institute for Age Research
Tom Kirkwood Newcastle University, Institute for Ageing and Health
Sylvia Lee Cornell University
Colleen Murphy Princeton University
Tom Neufeld University of Minnesota, Dept. of Genetics, Cell Biology and Development
Dean Ornish Preventive Medicine Research Institute
Linda Partridge University College London
Tom Perls Boston University, BU Alzheimer’s Disease Center
Pere Puigserver Dana-Farber Cancer Institute
Mark Roth Fred Hutchinson Cancer Research Center, Seattle, WA
Dave Sharp The University of Texas Health Science Center at San Antonio
Norman E. Sharpless The University of North Carolina School of Medicine
Li-Huei Tsai The Picower Institute
Marc Van Gilst Fred Hutchinson Cancer Research Center, Seattle, WA
Eric Verdin Gladstone Institute, UCSF
Amy Wagers Harvard Medical School, Biological and Biomedical Sciences
Bruce Yankner Harvard Medical School, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging
Sean P. Curran Massachusetts General Hospital
Dan Gottschling Fred Hutchinson Cancer Research Center
Stephen Helfand Brown University
Thomas E. Johnson University of Colorado at Boulder
Jan Karlseder Salk Institute for Biological Studies
Richard A. Miller University of Michigan
Arlan Richardson UT Health Science Center, San Antonio
Gary Ruvkun Massachusetts General Hospital Simches Research Center
Andrew V. Samuelson Massachusetts General Hospital
David J. Waters Center for Exceptional Longevity Studies
Geoffrey B. West Santa Fe Institute
Jonathan Weissman University of California, San Francisco
Nir Barzilai Albert Einstein College of Medicine
Holly Brown-Borg University of North Dakota School of Medicine & Health Sciences
Anja Brunet-Rossinni Santa Clara University
Irina Conboy UC Berkeley, Berkeley
Ana Maria Cuervo Albert Einstein College of Medicine
Michela Gallagher Johns Hopkins University
Peter Hornsby University of Texas Health Science Center
Yuji Ikeno University of Texas, San Antonio
Stuart Kim Stanford University
Shuji Kishi Harvard Medial School
Beverly Paigen The Jackson Laboratory
Thomas Rando Stanford University
Jeff Sekelsky University of North Carolina at Chapel Hill
Shring-Wern (Sharon) Tsaih The Jackson Laboratory
Julie Anderson Buck Institute for Age Research
Steven Austad University of Texas, San Antonio
Andrzej Bartke Southern Illinois University School of Medicine
Anne Brunet Stanford University
Rochelle Buffenstein University of Texas, San Antonio
Aubrey de Grey Methuselah Foundation
Andrew G. Dillin Salk Institute
Monica A. Driscoll Rutgers University
Jack Griffith University of North Carolina at Chapel Hill
Lenny Guarente Massachusetts Institute of Technology
Shin Imai Washington University School of Medicine
Donald Ingram Penniington Biomedical Research Center
Edward H. Koo University of California, San Diego
Roger McCarter The Pennsylvania State University
Gerald McClearn The Pennsylvania State University
Simon Melov Buck Institute for Age Research
Jim Nelson University of Texas, San Antonio
Fernando Nottebom The Rockefeller University
Leonard Shultz The Jackson Laboratory
Yousin Suh Albert Einstein College of Medicine
Marc Tatar Brown University
Heidi A. Tissenbaum University of Massachusetts Medical School
Trygve Tollefsbol University of Alabama at Birmingham
Robert Wessells University of Michigan
- The Grants Process: The Lifecycle of a Grant
- Electronic Submission, Electronic Research Administration (eRA)
- Grant Application Forms
- Preparing Grant Applications
- NIH Grant Review Process
- NCI Research and Funding: Questions and Answers
- NCI Extramural Glossary
- Program Announcements (PA)
Request for Applications (RFA)
- Requests for Proposals (RFP - Solicitations)
- Small Business Coordination (SBIT/STTR)
- Trans-NIH Initiatives (R01, R21)
- Trans-NIH Small Grants (R03)
–NCI and NIH Grant Submission and Review Policies
–Clinical Research/Human Subjects Policies and Guidelines
–NIH Grant Policies
- NCI Grant Activity Codes/Mechanisms & Descriptions
- NCI Grants and Training
- Building a Diverse Workforce
- NCI Other Funding (Contracts)
- NCI Office of Grants Administration
- Program Director Roster
- Research Program Contacts
- E-mail NCI Grants Referral Office
- Pancreatic Cancer Research Network
- Prostate Cancer Foundation
- Cancer Research Training
- Members / Roster
- Meeting Information (Agendas, Minutes, etc.)
- Funtion Statement
- Office of Federal Advisory Committee Policy
- Board Presentations
NCI and NIH Grant Submission and Review Policies
Clinical Research/Human Subjects Policies and Guidelines
NIH Grant Policies
NCI Full Year Funding Policy for RPG Awards FY 2024
- NCI Consumer Guide to Peer Review The NCI Consumer Guide to Peer Review has been prepared to serve first as an introduction and orientation to the National Cancer Institute (NCI) and its Research Programs and second to define your role as a consumer in the Peer Review of applications that support extramural clinical/population-based research conducted by Cancer Centers, Cooperative Groups, Program Projects, and projects submitted in response to Requests for Applications (RFAs) and Program Announcements (PAs).
- Cancer Dictionary for Peer Review Cancer Dictionary for Peer Review is deigned to provide concise definitions of technical terms frequently used in applications for NCI-sponsored investigator-initiated research. The terms include those commonly associated with the molecular biology of cancer, immunology, and clinical oncology. These definitions, in association with the review process, will increase your familiarity and understanding of the biology and clinical aspects of cancer. We hope this will facilitate and make your participation in the Peer Review process more meaningful.
- Office of Advocacy Relations
- NCI Council of Research Advocates
- The Research Portfolio Online Reporting Tools
NCI MISSION
The National Cancer Institute conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. For more information or to view the Institute's mission statement, please go to the NCI website: https://www.cancer.gov/about-nci .
BUDGET INFORMATION
Information on the FY 2024 budget can be found on the NCI Office of Budget and Finance website: https://www.cancer.gov/about-nci/budget
FUNDING STRATEGY
In FY 2024, decisions on competing grants will continue to be based on review of individual applications. Peer review evaluation of scientific merit will remain the primary consideration in these funding decisions, which will be made by the NCI Senior Executive Committee (SEC) following discussions with program staff. The SEC will continue its efforts to support early career investigators and give special consideration to applications that fill a significant gap in the cancer research portfolio or propose an especially novel or promising scientific approach.
NON-COMPETING AWARDS
NCI will generally fund both categorical and SNAP non-competing grants at 95% of the committed level. This policy applies to all grants, with the exception of the NRSAs, Career, Cancer Education, Continuing Education, P30 Cancer Centers, Conference, AIDS related grants, International Research Training Grants, Small Grants, Research Specialist, Pathway to Independence, SBIR, and STTR awards, which will be funded at committed levels. Non-competing grants that were awarded under the continuing resolution policy will be revised accordingly.
COMPETING AWARDS
Traditional research grants - experienced and new investigator (r01) & exploratory development grants (r21s).
Most Traditional (R01) Experienced and New Investigator applications with scores up to and including the 10th percentile and Exploratory Development (R21) applications with scores up to and including the 10th percentile will be funded without additional review. Final funding decisions on individual grants within this range are based on review of the applications by NCI program staff and grants management specialists and the negotiation of awards. Applications with higher scores require NCI division and SEC approval before final funding decisions are made. Information on the outcomes of grant selections from recent years can be viewed at: Awards of R01 and R21 Grants .
Early Stage Investigators (ESIs)
NCI is strongly committed to supporting early stage investigators (ESIs) and will place special emphasis on supporting these applicants. Most Traditional R01 selections submitted by ESIs with scores up to the 17th percentile will be funded without additional evaluation. Eligible ESI applications within the regular R01 payline of the 10th percentile will be considered for conversion to the R37 Method to Extend Research in Time (MERIT) Awards: Merit R37 Conversion notice . Traditional R01 applications submitted by New Investigators who are not ESIs will generally be funded up to the 10th percentile (same payline as the more experienced investigators). Current definitions and additional information regarding New and Early Stage Investigators can be found on the NIH's Office of Extramural Research website at: New Stage and Early Established Investigator Policies .
Program Projects (P01s)
All P01 applications will be individually evaluated for funding selection.
Small Grants (R03s) & AREA Grants (R15)
Small (R03) and AREA (R15) grant applications with scores up to and including 25 will likely be funded with no policy reductions. Applications with higher scores may be individually selected for funding depending on the availability of funds.
Large Dollar Amount R01s
All R01 applications with direct costs over $1,000,000 will be individually reviewed for funding selection.
RFA applications are considered for funding by the SEC. Success rates for RFAs will depend on the scientific merit and programmatic priority of each application, the number of applications submitted, and the amount of funds available. NCI does not consider it obligatory to use all funds set aside for any RFA. Please contact the program director listed on your summary statement if you have questions.
Competing RPG Funding Policy Reductions
- R01 & U01 Modular Applications : Competing renewals (Type-2s) will be funded at the NCI Type 2 cap level with no additional policy reductions applied. New Modular (R01) applications (Type-1s) with a direct cost $175 thousand or less will generally be funded at a 6.5% reduction from the Initial Review Group (IRG) recommended level and awards with a direct cost over $175 thousand will generally be funded at an 8.5% reduction. Foreign applications with direct costs under $250 thousand will be treated as modular grants in applying funding policy reductions.
- R01 & U01 Categorical (Non-modular) Applications : Competing renewals (Type-2s) will be funded at the NCI Type 2 cap level with no additional policy reductions applied. New Categorical Traditional (R01) grants (Type-1s) will generally be funded at a 17% reduction from the Initial Review Group (IRG) recommended level.
- R21 Applications : New (Type-1) applications requesting $175 thousand or less will generally be funded at a 6.5% reduction from the Initial Review Group (IRG) recommended level, and those requesting over $175 thousand in direct costs will generally be funded at an 8.5% reduction.
- Other Non-RFA RPG Reductions (P01, UM1, R33) : Competing renewals (Type-2s) will be funded at the NCI Type 2 cap level with no additional policy reductions applied. New (Type-1) applications requesting $175 thousand or less will generally be funded at a 13% reduction from the Initial Review Group (IRG) recommended level, and those requesting over $175 thousand in direct costs will generally be funded at a 17% reduction.
- Small Grant (R03)
- Academic Research Enhancement Award (R15)
- Research Specialist Award (R50)
- Small Business Innovation Research (R43/R44)
- Small Business Technology Transfer (R41/R42)
NCI Full Year Funding Policy for RPG Awards FY 2024 (PDF version)
Funding Policy for RPG Award Archive FY 2023-2010
Home | About DEA | Contact Us
Policies | Accessibility | FOIA | Vulnerability Disclosure Policy
NIH... Turning Discovery into Health
- OU Homepage
- The University of Oklahoma
Bin Wang Receives Friedrich Wilhelm Bessel Research Award
Kat Gebauer
Media Contact
Kat Gebauer (405) 325-1860 [email protected]
NORMAN, OKLA. – Bin Wang , a professor in the School of Sustainable Chemical, Biological and Materials Engineering at the University of Oklahoma, has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation. Wang was selected for his contributions to computational catalysis and physical chemistry.
The Bessel Award is funded by the German Federal Ministry of Education and Research to foster collaborative relationships between international academics and German researchers. The award includes a grant that supports up to 12 months of study in Germany.
In his research, Wang uses simulations to understand materials at the atomic level, providing insights into materials that can be used to accelerate chemical reactions. He will work with the Sustainable Materials Computational Materials Design department of the Max Planck Institute to use a machine learning approach to study solid-liquid interfacial chemistry. Wang says that because simulations of the solid-liquid interface include so much complexity, accurate simulation can be challenging. Machine learning techniques can help improve those simulations.
According to Wang, the collaboration could not come at a better time. Recently, OU’s School of Sustainable Chemical, Biological and Materials Engineering added “sustainable” to its name. “When people think about chemical engineering, the perception is that it’s all about oil and gas chemistry and operation,” he said. “That’s the reason [the school] changed the name, to show that our research and education is very broad and to achieve a sustainable future.”
This April, the Max Planck Institute for Iron Research did something similar, becoming the Max Planck Institute for Sustainable Materials.
“This really reflects what’s happening in the field right now. People are looking to sustainability and the challenges associated with it,” said Wang.
Wang has received numerous accolades during the span of his career, including an Early Career Award from the U.S. Department of Energy. He has been recognized as an Emerging Investigator by the Royal Society of Chemistry’s Catalysis Science & Technology and an Influential Researcher by the American Chemical Society’s Industrial & Engineering Chemistry Research .
About the award
The Friedrich Wilhelm Bessel Research award is granted by the Alexander von Humboldt Foundation annually to 20 international scholars from outside Germany in recognition of their research accomplishments and to foster international academic collaboration with German research institutions. Visit the Humboldt Foundation’s website to learn more about the award.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list . For more information about the university, visit ou.edu .
Recent News
Bin Wang, a professor in the School of Sustainable Chemical, Biological and Materials Engineering at the University of Oklahoma, has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation.
OU Health Stephenson Cancer Center at Norman Regional will Bring Research-driven Cancer Care to More Oklahomans
OU Health Stephenson Cancer Center and Norman Regional Health System celebrated a Topping Out Ceremony for the new cancer care facility on the Norman Regional HealthPlex campus, marking a significant milestone in the construction project and offering the community a first look at the new building.
Meteorology Field Work Offers Life-Changing Opportunities for OU Students
Students from OU's School of Meteorology are out in the field conducting atmospheric research year round. Those opportunities can shape their educations and their future careers.
- Accessibility
- Sustainability
- OU Job Search
- Legal Notices
- Resources and Offices
- OU Report It!
An official website of the United States government Here's how you know
Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
RAISE 2024 Awards
The list of RAISE 2024 awards can be found here: RAISE 2024 Award Fact Sheets
All RAISE 2024 applicants will be contacted. Successful applicants will receive an email with official grant award details notifying them of next steps. Unsuccessful applicants will receive an email with instructions for how to request a debrief.
- UB Directory
- Research and Economic Development >
- Need to Know and Events >
Eight UB researchers awarded over $4.7 million in NSF CAREER awards
research news
By ELIZABETH EGAN, PETER MURPHY and LAURIE KAISER
Published June 27, 2024
Eight UB researchers — seven from the School of Engineering and Applied Sciences (SEAS) and one from the School of Pharmacy and Pharmaceutical Sciences (SPPS) — have received National Science Foundation CAREER awards, one of the nation’s most prestigious honors for early-career engineers and scientists.
CAREER grants provide scholars with funding to conduct research and develop educational programming for K-12 students, university students and members of the public.
The SEAS recipients are Courtney Faber, Luis Herrera, Craig Snoeyink, Kang Sun, Yinyin Ye, Zhuoyue Zhao and Shaofeng Zou. The SPPS recipient is Jason Sprowl.
Together, the eight grantees will receive more than $4.7 million for projects that address pressing societal problems such as the need for more reliable artificial intelligence algorithms, preventing deaths from bacterial infections, mapping air pollution and better understanding how glucose moves throughout the human body.
“We take great pride in our eight faculty members who have been honored with this prestigious NSF award,” says Venu Govindaraju, vice president for research and economic development. “Their exceptional research is integral to UB’s mission of fostering a better world for all.”
Among the support that awardees receive is guidance from UB’s Office of Research Advancement, which is overseen by Chitra Rajan, associate vice president for research advancement. The office is managed by three co-directors — Joanna Tate, Maggie Shea and Menna Mbah — and provides a comprehensive suite of services, including proposal management, scientific editing, graphics and help with non-technical parts of the proposal.
These services, Rajan says, play a critical role in assisting faculty members in submitting high-quality proposals.
UB’s awardees are:
Courtney Faber , assistant professor of engineering education; award amount: $590,963.
When a research team is made up of people with various engineering and education backgrounds, different ideas of what knowledge is and how it is acquired can hinder team members’ ability to work cohesively.
Having firsthand experience with this issue, Faber’s goal is to support engineering education researchers who find themselves in a similar situation.
She will facilitate interdisciplinary work by identifying barriers that research teams face related to differences in thinking and creating ways to bring them to the surface for discussion before they become a problem.
“It’s important for the field of engineering education to be able to do this type of interdisciplinary work,” Faber says. “The problems we are trying to solve are very complex and require an interdisciplinary approach to make space for diversity of thinking.”
The project will involve observing research teams and conducting interviews to see how they function together, as well as how individual members think independently of the group.
Faber plans to develop trainings that new and established engineering education researchers can freely access.
She also hopes to create a tool that assists research groups in integrating approaches and goals that might otherwise be problematic for a group. The tool could be as simple as a one-page guide that provides questions to be considered throughout the research process to help identify where a team’s ideas might differ across various aspects of their research.
Luis Herrera , assistant professor of electrical engineering; award amount: $500,000.
Herrera’s research lies at the intersection of power electronics, power systems and control theory.
With this grant, he is developing different control methods to promote the wider adoption of direct current (DC) microgrids, which can run more efficiently than the more commonly used AC (alternating current) microgrids.
“Currently, DC electrical systems are primarily used in applications such as electric aircrafts, including the Boeing 787 Dreamliner; navy ships; and data centers,” Herrera says. “However, most renewable energy sources are interfaced to the AC power grid through an intermediate DC stage.”
More networks operated through DC grids could significantly increase energy efficiency, reduce losses and improve the overall operation of electrical systems, he explains.
This potential creates motivation for DC systems to be implemented in commonly used structures, such as residential and office buildings.
Graduate students will participate in a summer internship at the Air Force Research Laboratory through a partnership with the University of Dayton Research Institute.
Herrera also plans to create demonstrations of the research and present them to elementary, middle school and high school students, aiming to get students excited about STEM early in their academic careers.
Craig Snoeyink , assistant professor of mechanical and aerospace engineering; award amount: $581,088 .
Water filtration, whiskey distillation and blood-based diagnostics are just a few of the potential applications of dielectrophoretic molecular transport (DMT), a process that uses strong electric fields to push solutes out of water. This even includes those such as sugar and alcohol that do not have an electrical charge.
DMT is not used, however, due to the inaccuracy of current mathematical models.
With his grant, Snoeyink will develop and validate models for DMT for use in these applications. With one of the first accurate models of DMT, the process could be used, for example, to clean water as effectively as a water filter that never needs to be changed.
Snoeyink notes that point-of-care diagnostics are another significant application.
“Down the line, we could use this technology to separate blood into components we want to test and stuff we don’t, making medical diagnostics cheaper and more sensitive,” he says.
To help with testing and to offer students research opportunities that could propel them into graduate school, Snoeyink will teach a course for students to do research for the project as part of their curriculum. With his guidance, students will run tests and create their own hypothesis. He hopes students will have papers based on their research that will bolster their graduate school applications.
Jason A. Sprowl , assistant professor of pharmaceutical sciences; award amount: $746,886.
Sodium-glucose-linked transporters (SGLT) work like little doors in human cells that help bring in glucose, an important type of sugar that fuels the human body. Without the right amount of glucose, an individual can experience nutrient deficiencies and other health issues.
Unfortunately, cellular events that regulate SGLT activity are poorly understood. This is particularly true for tyrosine phosphorylation, a form of modification that can change protein structure and function.
For his research project, Sprowl will study how tyrosine phosphorylation regulates changes in glucose movement into cells. He’ll use techniques like genetic manipulation and mass spectrometry to see how changing the tyrosine phosphorylation state of SLGTs affects its ability to let glucose into a cell. Finally, he will try to figure out which tyrosine kinases are responsible for phosphorylating SGLTs.
The project also includes several strategies for educational improvements at the middle school, high school and university levels. They include highlighting the biological importance of SGLTs, as well as the training and recruitment of junior scientists who will lead future research efforts. Collectively, the project is expected to impact many scientific disciplines, including molecular, cellular and systems biology.
To improve basic scientific knowledge, generate a passion for research and improve leadership capabilities in the field of biological sciences, Sprowl plans to establish an annual summer research position for underprivileged high school students. He also will work with middle school educators to increase recognition of reproducible and high-quality science, and develop online content that will increase familiarity with transporter proteins.
Kang Sun , assistant professor of civil, structural and environmental engineering; award amount: $643,562.
Sun has been interested in astronomy since he was a young child. He’s currently fascinated by the idea of pointing a space telescope toward Earth and imaging emission sources like celestial objects.
With the research grant, Sun will map global emission sources of gaseous air pollutants and greenhouse gases. Such gases are invisible to the human eye. While they can be detected by satellites, their images are naturally smeared due to wind dispersion.
“This research removes the smearing effect using a simple and elegant equation that originates from mass balance,” Sun explains. “The results are timely and precise estimates of emissions that can inform policy and scientific studies.”
Currently, the two mainstream, emission-estimating methods are bottom-up, accounting for activities on the ground and how they emit, and top-down, inferring emissions with observations, numerical models and complicated frameworks that are usually region-specific.
Sun’s method will fall within the scope of the latter but will work faster, be globally applicable and provide the high spatial resolutions that are more commonly achieved by the bottom-up method.
The results will resemble a space-telescope image, with significant emission sources standing out like galaxies and smaller sources, such as towns and power plants, sprinkled about like star clusters.
By the end of the five-year study, Sun hopes students and educators may use his open-source algorithms to generate satellite-based concentration and emission maps on their personal computers.
Yinyin Ye , assistant professor of civil, structural and environmental engineering; award amount: $580,393.
Bacterial infections cause more than 300,000 deaths annually in the United States. Many of these infections are triggered by proteins secreted from bacteria in lipid-containing particles called extracellular vesicles (EV). These harmful materials move from the human body through feces into the sewer systems, where their fate is not fully understood.
With the research grant, Ye will monitor EV persistence and stability in wastewater and throughout the wastewater-treatment process. She will analyze functions of environmental EV and what contents are packed in them, and develop an analysis method that integrates genome sequencing and proteomic analysis.
“If the vesicles preserve the function of virulence proteins in wastewater, we need to better understand the fate of the vesicles when they go through the treatment chain,” Ye says. “How are we able to minimize the health risks of vesicles after the treatment at the wastewater treatment plants? If they escape the treatment process and are still active, that can have certain health impacts.”
Ye’s project will focus on wastewater samples. However, these approaches can be applied to analyzing vesicles and their potential health risks in air dust, drinking water and rainwater, she notes. Ultimately, this work will help determine what harmful materials — if any — are still present after the wastewater-treatment process and how to remove them most effectively through disinfection.
She will also create hands-on activities to engage K-12 and undergraduate students in learning about wastewater microbiome analysis and microbial risk mitigation for public health and potentially build their interest in environmental engineering.
Zhuoyue Zhao , assistant professor of computer science and engineering; award amount: $599,977.
Today’s internet databases hold large volumes of data that are processed at higher speeds than ever before.
A new type of database system, hybrid transactional/analytical processing (HTAP), allows for real-time data analytics on databases that undergo constant updates.
“While real-time data analytics can provide valuable insights for applications such as marketing, fraud detection and supply chain analytics, it is increasingly hard to ensure a sufficiently low response time of query answering in existing HTAP systems,” Zhao says.
Approximate query processing (AQP) is a faster alternative that uses random sampling. However, many AQP prototypes and adopted systems sacrifice query efficiency or the ability to handle rapid updates correctly.
With the research grant, Zhao aims to support real-time data analytics on large and rapidly growing databases by enabling reliable AQP capabilities in HTAP systems, leading to increasingly demanding, real-time analytics applications.
“If this problem is solved, it will potentially make it possible to finally adopt AQP in many existing database systems and create sizable impacts on real-world data analytics applications,” Zhao explains.
Zhao will incorporate new material into existing UB undergraduate- and graduate-level courses, as well as offer tutorials and projects in various K-12 outreach and undergraduate experiential learning programs.
Shaofeng Zou , assistant professor of electrical engineering; award amount: $520,000.
Reinforcement learning (RL) is a type of machine learning that trains autonomous robots, self-driving cars and other intelligent agents to make sequential decisions while interacting with an environment.
Many RL approaches assume the learned policy will be deployed in the same — or similar — environment as the one it was trained in. In most cases, however, the simulated environment is vastly different from the real world — such as when a real-world environment is mobile while a simulated environment is stationary. These differences often lead to major disruptions in industries using RL, including health care, critical infrastructure, transportation systems, education and more.
Zou’s award will fund his work developing RL algorithms that do not require excessive resources, and that will perform effectively under the most challenging conditions, including those outside of the training environment. According to Zou, the project could have a significant impact on both the theory and practice of sequential decision-making associated with RL in special education, intelligent transportation systems, wireless communication networks, power systems and drone networks.
“The activities in this project will provide concrete principles and design guidelines to achieve robustness in the face of model uncertainty,” Zou says. “Advances in machine learning and data science will transform modern humanity across nearly every industry. They are already the main driver of emerging technologies.
“The overarching goal of my research is to make machine learning and data science provably competent.”
IMAGES
VIDEO
COMMENTS
Cluster network of scientific publications in relation to Nobel prizes.. In July 2020 scientists reported that work honored by Nobel prizes clusters in only a few scientific fields with only 36/71 having received at least one Nobel prize of the 114/849 domains science could be divided into according to their DC2 and DC3 classification systems. Five of the 114 domains were shown to make up over ...
Research awards and prizes. A list of some recently published awards and prizes that recognize scientific achievement and contributions to research culture. Robert W. Berliner Award for Excellence in Renal Physiology (worldwide) Read More »
Three (3) awards of $10,000 and seven (7) awards of $5,000 are offered each year. Recognizes outstanding graduate student research in psychology. Twenty-one (21) awards of $2,000-$5,000 are offered each year. Funding for promising research early in doctoral training. Five (5) awards of $1,000 are offered each year.
The newly launched NOMIS & Science Young Explorer Award recognizes bold, early-career researchers with an M.D., Ph.D. or M.D./Ph.D. who ask fundamental questions at the intersection of the social and life sciences. It is awarded to scientists who conduct research with an enthusiasm that catalyzes cross-disciplinary collaboration and who take ...
The Fulbright U.S. Scholar Program offers over 400 awards in more than 135 countries for U.S. citizens to teach, conduct research and carry out professional projects around the world. College and university faculty, as well as artists and professionals from a wide range of fields can join over 400,000 Fulbrighters who have come away with ...
25374-AU. Fulbright Scholar Award (University of Technology Sydney) (25374-AU) Australia. Research. East Asia and the Pacific. Compare. 25354-AT. Fulbright-Botstiber Visiting Professor of Austrian-American Studies in Austria.
Annual. Basic Science Research, Cancer, Cell Biology, Clinical Research, Genetics, Immunology, Regenerative Medicine. In the case of unlimited submission prizes, nominators do not need to go through the Dean of the Faculty of Medicine's office. Louis and Artur Lucian Award for Research in Circulatory Diseases.
Amazon Research Awards was founded in 2015 and merged with AWS Machine Learning Research Awards (MLRA) in 2020. The ARA program offers unrestricted cash awards and AWS Promotional Credits to fund research at academic institutions and non-profit organizations in areas that align with our mission to advance customer-obsessed science.
The Inclusive Health Research awards have been established by Nature Awards in partnership with Takeda to celebrate those who are driving a more inclusive approach to health research and, in doing ...
FARE is sponsored by the NIH Fellows Committee (FelCom), the Scientific Directors, and the NIH Office of Intramural Training & Education, and is funded by the Scientific Directors.Fellows submit an abstract of their research, which is peer reviewed in a blind study section competition. Authors of abstracts with the top 25% of scores are recognized as FARE winners.
Open Study/Research Award. 2025-2026 Competition Deadline: Tuesday October 8, 2024 at 5 pm Eastern Time. Applicants for study/research awards design their own projects and will typically work with advisers at foreign universities or other institutes of higher education. The study/research awards are available in approximately 140 countries.
The Research Achievement Awards recognize University of Virginia faculty every year for their excellence in research and scholarship. We believe we are what we celebrate, so every year we recognize the accomplishments of our faculty. We also run a news story to highlight the 100 top research ers as the best and brightest of the year based on sponsored funding, publications, and awards.
Contact us for more info. National Academy of Sciences Awards (18 Individual Awards Available) National Academy of Sciences. Various, including STEM, Psychology, Humanities. $20- 100K. October 5. Self-nominations not permitted. Dr H.P. Heineken Prize (5) Royal Netherlands Academy of Arts and Sciences (KNAW)
The new set of awards will be administered by the National Institute of Dental and Craniofacial Research on behalf of the NIH. About the NIH Common Fund: The NIH Common Fund encourages collaboration and supports a series of exceptionally high-impact, trans-NIH programs. Common Fund programs are managed by the Office of Strategic Coordination in ...
Fellows' Career Development. FARE is the acronym for the Fellows Award for Research Excellence, begun in 1995 to recognize the outstanding scientific research performed by intramural postdoctoral fellows. The award is sponsored by the NIH Fellows Committee, the Scientific Directors, and the NIH Office of Intramural Training & Education, and is ...
Lasker Awards. The National Institutes of Health (NIH) has a long, rich tradition of support for award-winning, cutting-edge research. Many of the world's most distinguished investigators have been honored with medicine's top prizes, including the Nobel Prize and awards from the Albert and Mary Lasker Foundation — "America's Nobels ...
The nomination period is open from July 1 to November 1 annually. Learn more about submitting a nomination for the ACS National Awards. Sponsor. Sponsored by Research Corporation for Science Advancement. History. Research Corporation for Science Advancement, a private foundation for the advancement of science, established the award in 1984.
The Award for Inclusion Research Program recognizes and supports academic research in computing and technology that addresses the needs of historically marginalized groups globally. Launched in 2020, the Award for Inclusion Research (AIR) Program is an ongoing effort to support innovative research and professors working to create positive ...
Contact Information. Please direct all inquiries pertaining to this Award or any other AACR scientific achievement award or lecture to Michael J. Powell, PhD, Senior Director of Scientific Programs and Strategic Initiatives, at [email protected] or by phone at (215) 440-9373.
Since 1961, the AACR has been proud to recognize scientific excellence across the spectrum of basic, translational, clinical, and epidemiological cancer research through a robust collection of annual awards and lectureships that serve to honor laboratory researchers, physician-scientists, and population scientists who have made significant contributions to our understanding of the diagnosis ...
Alauddin Ahmed, Hugo Carreno-Luengo and Hsing-Fang Hsieh will receive the Research Faculty Recognition Award, while Jason Goldstick, Kathryn Luker and John Nees will receive the Research Faculty Achievement Award. All six will be recognized at the President's Faculty Awards event this fall. OVPR's annual research recognition awards ...
IJCAI-24 Award for Research Excellence: The Research Excellence award is given to a scientist who has carried out a program of research of consistently high quality throughout an entire career yielding several substantial results. Past recipients of this honor are the most illustrious group of scientists from the field of Artificial Intelligence.
The Discovery Awards encourage faculty from various disciplines to collaborate in addressing multifaceted challenges and pushing the boundaries of understanding. 2024 awarded projects will launch a wide range of inquiry - creating DNA-based hydrogel bioinks with enhanced mechanical properties for advanced 3D bioprinting applications, such as ...
Cary, NC (June 24, 2024) - The V Foundation for Cancer Research, a top-rated cancer charity, is proud to announce the second annual recipient class of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research.Fifteen exceptional women scientists were selected for their groundbreaking cancer research studies, with the V Foundation investing $10.2 million this year - and ...
The Glenn Award was initiated in 2007, to provide unsolicited funds to researchers investigating the biology of aging. The grants are to assist scientists where funding shortages threaten to impede scientific progress. Award recipients are selected from nominees provided by an anonymous scientific advisory committee. Applications are not accepted.
Research Specialist Award (R50) Small Business Innovation Research (R43/R44) Small Business Technology Transfer (R41/R42) NCI Full Year Funding Policy for RPG Awards FY 2024 (PDF version) Funding Policy for RPG Award Archive FY 2023-2010. President's Cancer Panel Twitter Feed: NCI YouTube Series
NORMAN, OKLA. - Bin Wang, a professor in the School of Sustainable Chemical, Biological and Materials Engineering at the University of Oklahoma, has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation.Wang was selected for his contributions to computational catalysis and physical chemistry. The Bessel Award is funded by the German Federal Ministry of ...
The list of RAISE 2024 awards can be found here: RAISE 2024 Award Fact Sheets . All RAISE 2024 applicants will be contacted. Successful applicants will receive an email with official grant award details notifying them of next steps. Unsuccessful applicants will receive an email with instructions for how to request a debrief.
Luis Herrera, assistant professor of electrical engineering; award amount: $500,000.. Herrera's research lies at the intersection of power electronics, power systems and control theory. With this grant, he is developing different control methods to promote the wider adoption of direct current (DC) microgrids, which can run more efficiently than the more commonly used AC (alternating current ...
Process post award documents to establish new, amended and NCEs for awards/accounts in the financial system (Workday) ... Monitors allowable and unallowable costs on sponsored research X; Primary Oversight; Monitor Over 90 Day Cost Transfers (personnel and non-personnel) X; Primary Request and process budget amendments;